UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark one)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2010~~2011

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file numbers:

001-32701

333-127115

EMERGENCY MEDICAL SERVICES CORPORATION

EMERGENCY MEDICAL SERVICES L.P.

(Exact name of Registrants as Specified in their Charters)

		20-3738384
Delaware		20-2076535
(State or other jurisdiction of		(IRS Employer
incorporation or organization)		Identification Numbers)

6200 S. Syracuse Way, Suite 200
Greenwood Village, CO		80111
(Address of principal executive offices)		(Zip Code)

Registrants’ telephone number, including area code: 303-495-1200

Former name, former address and former fiscal year, if changed since last report:

Not applicable

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). o Yes o x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ox Accelerated filer xo Non-accelerated filer o Smaller reporting company o (Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange act). Yes o No x

Shares of class A common stock outstanding at ~~October~~ April 29, ~~2010~~2011 — 30,~~315~~485,~~886~~293; shares of class B common stock outstanding at ~~October~~ April 29, ~~2010~~2011 — 6552,~~052~~228; LP exchangeable units outstanding at ~~October~~ April 29, ~~2010~~2011 — 13,724,676.

Table of Contents

EMERGENCY MEDICAL SERVICES CORPORATION

INDEX TO QUARTERLY REPORT

ON FORM 10-Q

FOR THE THREE ~~AND NINE~~ MONTHS ENDED

~~SEPTEMBER 30~~MARCH 31, ~~2010~~2011

Part 1. Financial Information		3			3
~~Item 1.~~	~~Financial Statements (Unaudited):~~	3Item 1.		Financial Statements (Unaudited):	3
	~~Consolidated Statements of Operations and Comprehensive Income~~	3		Consolidated Statements of Operations and Comprehensive Income	3
	~~Consolidated Balance Sheets~~	4		Consolidated Balance Sheets	4
	~~Consolidated Statements of Cash Flows~~	5		Consolidated Statements of Cash Flows	5
	~~Notes to Unaudited Consolidated Financial Statements~~	6		Notes to Unaudited Consolidated Financial Statements	6
~~Item 2.~~	~~Management’s Discussion and Analysis of Financial Condition and Results of Operations~~	20Item 2.		Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
~~Item 3.~~	~~Quantitative and Qualitative Disclosures About Market Risk~~	30Item 3.		Quantitative and Qualitative Disclosures About Market Risk	25
~~Item 4.~~	~~Controls and Procedures~~	30Item 4.		Controls and Procedures	25
Part II. Other Information		31			27
~~Item 1.~~	~~Legal~~Item ~~Proceedings~~1.	31	Legal Proceedings		27
~~Item 1A.~~	~~Risk~~Item ~~Factors~~1A.	31	Risk Factors		27
~~Item 6.~~	~~Exhibits~~Item 6.	32	Exhibits		29
Signatures		33			30

Table of Contents

EMERGENCY MEDICAL SERVICES CORPORATION

PART I. FINANCIAL INFORMATION

FOR THE THREE ~~AND NINE~~ MONTHS ENDED

~~SEPTEMBER 30~~MARCH 31, ~~2010~~2011

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

Emergency Medical Services Corporation

Consolidated Statements of Operations and Comprehensive Income

(unaudited; in thousands, except share and per share data)

	Quarter ended						~~Nine months ended~~
	September 30,						September 30,
	March 31,
	2010			2009			2010			2009
	2011			2010
Net revenue	$	~~737~~760,~~180~~835		$	~~665~~679,~~056~~354		$	~~2,125,338~~		$	~~1,915,369~~
Compensation and benefits	~~523~~537,~~263~~077			~~467~~480,~~625~~317			~~1,500,023~~			~~1,332,787~~
Operating expenses	9196,~~023~~963			8586,~~510~~529			~~268,138~~			~~252,355~~
Insurance expense	2526,~~793~~539			2422,~~845~~070			~~73,805~~			~~75,706~~
Selling, general and administrative expenses	17,~~742~~835			1516,~~871~~858			~~52,898~~			~~47,186~~
Depreciation and amortization expense	1617,~~528~~525			1516,~~733~~180			~~48,400~~			~~48,658~~
Income from operations	6264,~~831~~896			5557,~~472~~400			~~182,074~~			~~158,677~~
Interest income from restricted assets	~~717~~396			~~1,082~~855			~~2,431~~			~~3,468~~
Interest expense	(4,~~856~~817		)	(108,~~280~~266		)	~~(18,182~~		)	~~(30,749~~		)
Realized gain on investments	730			544			879			2,030
Realized (loss) gain on investments	(4		)	92
Interest and other income	277			502			748			1,442
Interest and other (expense) income	(1,746		)	265
Loss on early debt extinguishment	—			—			(19,091		)	—
Income before income taxes and equity in earnings of unconsolidated subsidiary	58,725			50,346
Income before income taxes and equity in earnings of unconsolidated subsidiary	59,699			47,320			148,859			134,868
Income tax expense	(22,652		)	(19,410		)
Income tax expense	(22,990		)	(18,533		)	(57,355		)	(53,144		)
Income before equity in earnings of unconsolidated subsidiary	36,073			30,936
Income before equity in earnings of unconsolidated subsidiary	36,709			28,787			91,504			81,724
Equity in earnings of unconsolidated subsidiary	91			94
Equity in earnings of unconsolidated subsidiary	53			91			252			244
Net income	36,164			31,030
Net income	36,762			28,878			91,756			81,968
Other comprehensive income, net of tax:
Other comprehensive income (loss), net of tax:
Unrealized holding gains during the period	629			442
Unrealized holding gains (losses) during the period	364			761			1,907			(1,773		)
Unrealized gains on derivative financial instruments	984			478
Unrealized gains on derivative financial instruments	330			1,105			245			2,372
Comprehensive income	$	37,777		$	31,950
Comprehensive income	$	37,456		$	30,744		$	93,908		$	82,567
Basic earnings per common share	$	0.82		$	0.71
Basic earnings per common share	$	0.83		$	0.67		$	2.09		$	1.93
Diluted earnings per common share	$	0.80		$	0.70
Diluted earnings per common share	$	0.82		$	0.66		$	2.06		$	1.89
Weighted average common shares outstanding, basic	44,247,581			43,571,705
Weighted average common shares outstanding, basic	44,100,239			42,809,582			43,896,524			42,366,065
Weighted average common shares outstanding, diluted	45,012,235			44,534,858
Weighted average common shares outstanding, diluted	44,699,169			43,769,788			44,648,135			43,402,818

The accompanying notes are an integral part of these financial statements.

Table of Contents

Emergency Medical Services Corporation

Consolidated Balance Sheets

(in thousands, except share and per share data)

	September 30,			December 31,
	March 31, 2011			December 31, 2010
	2010			2009
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	~~345~~334,~~716~~772		$	~~332~~287,~~888~~361
Insurance collateral	2824,~~231~~499			2433,~~986~~476
Trade and other accounts receivable, net	~~492~~505,~~723~~133			~~459~~489,~~088~~658
Parts and supplies inventory	2223,~~759~~332			2223,~~270~~031
Prepaids and other current assets	1724,~~251~~386			1918,~~662~~617
Current deferred tax assets	—			6,323
Total current assets	912,122			852,143
Total current assets	906,680			865,217
Non-current assets:
Property, plant and equipment, net	~~126~~139,~~759~~346			~~125~~133,~~855~~731
Intangible assets, net	~~138~~173,~~641~~714			~~102~~180,~~654~~374
Non-current deferred tax assets	6,723			13,468
Insurance collateral	133,263			136,063
Insurance collateral	151,949			143,886
Goodwill	453,920			427,405
Goodwill	388,506			381,951
Other long-term assets	17,617			18,836
Other long-term assets	18,748			21,676
Total assets	$	1,829,982		$	1,748,552
Total assets	$	1,738,006		$	1,654,707
Liabilities and Equity
Current liabilities:
Accounts payable	$	6849,~~239~~309		$	7039,~~759~~581
Accrued liabilities	~~264~~287,~~603~~779			~~273~~259,~~704~~638
Current deferred tax liability	11,068			—
Current deferred tax liabilities	5,614			5,114
Current portion of long-term debt	1319,~~953~~723			416,~~676~~333
Total current liabilities	~~357~~362,~~863~~425			~~349~~320,~~139~~666
Long-term debt	~~410~~399,~~307~~587			~~449~~404,~~254~~943
Insurance reserves and other long-term liabilities	166,152			170,227
Long-term deferred tax liabilities	5,971			5,971
Total liabilities	934,322			968,620
Insurance reserves and other long-term liabilities	174,638			169,767
Total liabilities	942,621			901,347
Equity:
Preferred stock ($0.01 par value; 20,000,000 shares authorized, 0 issued and outstanding)	—			—
Class A common stock ($0.01 par value; 100,000,000 shares authorized, 30,294,976 and 29,541,411 issued and outstanding in 2010 and 2009, respectively)	303			295
Class A common stock ($0.01 par value; 100,000,000 shares authorized, 30,485,118 and 30,404,572 issued and outstanding in 2011 and 2010, respectively)	305			304
Class B common stock ($0.01 par value; 40,000,000 shares authorized and 65,052 issued and outstanding in 2010 and 2009, respectively)	1			1
Class B common stock ($0.01 par value; 40,000,000 shares authorized, 52,228 and 65,052 issued and outstanding in 2011 and 2010, respectively)	1			1
Class B special voting stock ($0.01 par value; 1 share authorized, issued and outstanding in 2010 and 2009)	—			—
Class B special voting stock ($0.01 par value; 1 share authorized, issued and outstanding in 2011 and 2010)	—			—
LP exchangeable units (13,724,676 units issued and outstanding in 2010 and 2009, respectively)	90,776			90,776
LP exchangeable units (13,724,676 shares issued and outstanding in 2011 and 2010)	90,776			90,776
Treasury stock at cost (23,437 shares in 2010)	(1,289		)	—
Treasury stock at cost (51,247 and 30,778 shares in 2011 and 2010, respectively)	(2,987		)	(1,684		)
Additional paid-in capital	~~300~~308,~~286~~939			~~275~~305,~~316~~258
Retained earnings	~~410~~486,~~798~~930			~~319~~450,~~042~~766
Accumulated other comprehensive income	23,~~809~~397			~~657~~1,784
Total equity	~~803~~887,~~684~~361			~~686~~847,~~087~~205
Total liabilities and equity	$	1,~~738~~829,~~006~~982		$	1,~~654~~748,~~707~~552

The accompanying notes are an integral part of these financial statements.

Table of Contents

Emergency Medical Services Corporation

Consolidated Statements of Cash Flows

(unaudited; in thousands)

	Quarter ended September 30,						Nine months ended September 30,
	Quarter ended March 31,
	2010			2009			2010			2009
	2011			2010
Cash Flows from Operating Activities
Net income	$	36,~~762~~164		$	2831,~~878~~030		$	~~91,756~~		$	~~81,968~~
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1718,~~165~~315			16,~~242~~687			~~50,173~~			~~49,983~~
Loss on disposal of property, plant and equipment	639			3344			95			69
Equity-based compensation expense	21,~~042~~962			1,~~121~~104			~~4,587~~			~~2,875~~
Excess tax benefits from stock-based compensation	(~~479~~1,169		)	—(10,581		)	~~(13,977~~		)	—
Loss on early debt extinguishment	—			—			19,091			—
Equity in earnings of unconsolidated subsidiary	(91		)	(94		)
Equity in earnings of unconsolidated subsidiary	(53		)	(91		)	(252		)	(244		)
Dividends received	427			403
Dividends received	—			—			403			713
Deferred income taxes	345			(133		)
Deferred income taxes	(1,102		)	18,061			(262		)	49,989
Changes in operating assets/liabilities, net of acquisitions:
Changes in operating assets/liabilities, net of acquisitions:
Trade and other accounts receivable	(10,762		)	2,191
Trade and other accounts receivable	(10,882		)	7,574			(30,441		)	8,448
Parts and supplies inventory	(81		)	(162		)
Parts and supplies inventory	(231		)	41			(318		)	(66		)
Prepaids and other current assets	(4,741		)	(3,388		)
Prepaids and other current assets	14,487			(6,270		)	2,271			(1,580		)
Accounts payable and accrued liabilities	29,087			6,006
Accounts payable and accrued liabilities	799			(1,007		)	13,898			10,613
Insurance accruals	2,504			1,478
Insurance accruals	(3,891		)	4,280			2,341			7,033
Net cash provided by operating activities	71,999			44,585
Net cash provided by operating activities	54,623			68,862			139,365			209,801
Cash Flows from Investing Activities
Cash Flows from Investing Activities
Purchases of property, plant and equipment	(15,306		)	(6,516		)
Purchases of property, plant and equipment	(16,199		)	(13,576		)	(31,367		)	(33,661		)
Proceeds from sale of property, plant and equipment	10			42
Proceeds from sale of property, plant and equipment	12			41			120			101
Acquisition of businesses, net of cash received	(32,720		)	(3,300		)
Acquisition of businesses, net of cash received	(183		)	(1,241		)	(51,158		)	(1,374		)
Net change in insurance collateral	12,406			2,366
Net change in insurance collateral	(4,140		)	6,002			(9,401		)	4,069
Other investing activities	474			290
Other investing activities	83			(166		)	11,021			(809		)
Net cash used in investing activities	(35,136		)	(7,118		)
Net cash used in investing activities	(20,427		)	(8,940		)	(80,785		)	(31,674		)
Cash Flows from Financing Activities
Cash Flows from Financing Activities
EMSC issuance of class A common stock	551			4,402
EMSC issuance of class A common stock	221			2,437			6,414			7,160
Class A common stock repurchased as treasury stock	(1,303		)	—
Class A common stock repurchased as treasury stock	(1,289		)	—			(1,289		)	—
Repayments of capital lease obligations and other debt	(1,966		)	(1,184		)
Repayments of capital lease obligations and other debt	(3,275		)	(1,214		)	(455,902		)	(3,826		)
Excess tax benefits from stock-based compensation	1,169			10,581
Borrowings under credit facility	—			—			425,000			—
Net change in bank overdrafts	12,097			(3,099		)
Debt issue costs	(219		)	—			(11,968		)	—
Net cash provided by financing activities	10,548			10,700
Payment for debt extinguishment premiums	—			—			(14,513		)	—
Change in cash and cash equivalents	47,411			48,167
Excess tax benefits from stock-based compensation	479			—			13,977			—
Cash and cash equivalents, beginning of period	287,361			332,888
Net change in bank overdrafts	2,570			2,821			(7,471		)	3,471
Cash and cash equivalents, end of period	$	334,772		$	381,055
Net cash (used in) provided by financing activities	(1,513		)	4,044			(45,752		)	6,805
Change in cash and cash equivalents	32,683			63,966			12,828			184,932
Cash and cash equivalents, beginning of period	313,033			267,139			332,888			146,173
Cash and cash equivalents, end of period	$	345,716		$	331,105		$	345,716		$	331,105

The accompanying notes are an integral part of these financial statements.

Table of Contents

Emergency Medical Services Corporation

Notes to Unaudited Consolidated Financial Statements

(in thousands, except share and per share data)

1. General

Basis of Presentation of Financial Statements

The accompanying interim consolidated financial statements for Emergency Medical Services Corporation (“EMSC” or the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim reporting and, accordingly, do not include all of the disclosures required for annual financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal, recurring nature. Operating results for the three ~~and~~ ~~nine~~months ~~month periods~~ ended ~~September 30~~March 31, ~~2010~~2011 are not necessarily indicative of the results that may be expected for the full year ending December 31, ~~2010~~ 2011. For further information, see the Company’s consolidated financial statements, including the accounting policies and notes thereto, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, ~~2009~~2010.

The consolidated financial statements of EMSC include those of its direct subsidiary, Emergency Medical Services L.P. (“EMS LP”), a Delaware limited partnership. The Company’s business is conducted primarily through two operating subsidiaries, American Medical Response, Inc. (“AMR”), its ~~healthcare~~ medical transportation services segment, and EmCare Holdings Inc. (“EmCare”), its facility-based physician services segment.

The Company is party to a management agreement with a wholly-owned subsidiary of Onex Corporation, the Company’s principal equityholder. In exchange for an annual management fee of $1.0 million, the Onex subsidiary provides the Company with corporate finance and strategic planning consulting services. For ~~each of~~ the three ~~and nine~~ months ended ~~September 30~~March 31, ~~2010~~2011 and ~~2009~~2010, the Company expensed $250 ~~and $750, respectively,~~ in respect of this fee.

Merger Agreement

On February 13, 2011, the Company entered into an Agreement and Plan of Merger (“Merger Agreement”) with CDRT Acquisition Corporation, a Delaware corporation (“Parent”), and CDRT Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Sub”). Parent and Sub are affiliates of Clayton, Dubilier & Rice, LLC. Pursuant to the Merger Agreement and subject to the conditions set forth therein, Sub will merge with and into the Company (the “Merger”) with the Company as the surviving entity and a wholly-owned subsidiary of Parent. At the time the Merger is effective, each issued and outstanding share of class A common stock and class B common stock (including shares of Class B common stock issued immediately prior to the effective time of the Merger in exchange for the LP exchangeable units of EMS LP, but excluding treasury shares, shares held by Parent or Sub and shares held by stockholders who perfect their appraisal rights), will be converted into the right to receive $64.00 per share in cash, without interest and subject to any applicable withholding taxes.

2. Summary of Significant Accounting Policies

Consolidation

The consolidated financial statements include all wholly-owned subsidiaries of EMSC, including AMR and EmCare and their respective subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements requires management to make estimates and assumptions relating to the reporting of results of operations, financial condition and related disclosure of contingent assets and liabilities at the date of the financial statements. Actual results may differ from those estimates under different assumptions or conditions.

Insurance

Insurance collateral is comprised principally of government and investment grade securities and cash deposits with third parties and supports the Company’s insurance program and reserves. Certain of these investments, if sold or otherwise liquidated, would have to be replaced by other suitable financial assurances and are, therefore, considered restricted.

Insurance reserves are established for automobile, workers compensation, general liability and professional liability claims utilizing policies with both fully-insured and self-insured components. This includes the use of an off-shore captive insurance program through a wholly-owned subsidiary for certain liability programs for both EmCare and AMR. In those instances where the Company has obtained third-party insurance coverage, the Company ~~generally~~ normally retains liability for the first $1 to $2 million of the loss. Insurance reserves cover known claims and incidents within the level of Company retention that may result in the assertion of additional claims, as well as claims from unknown incidents that may be asserted arising from activities through the balance sheet date.

The Company establishes reserves for claims based upon an assessment of actual claims and claims incurred but not reported. The reserves are established based on quarterly consultation with third-party independent actuaries using actuarial principles and assumptions that consider a number of factors, including historical claim payment patterns (including legal costs), and changes in case reserves and the assumed rate of inflation in healthcare costs and property damage repairs.

The Company’s most recent actuarial valuation was completed in ~~September 2010~~March 2011. As a result of this and previous actuarial ~~valuation~~valuations, the Company recorded an increase ~~of $0.1 million~~ in its ~~provision~~provisions for insurance liabilities ~~related~~of toapproximately ~~reserves~~$2.5 ~~for losses~~million in ~~prior years during~~ the three months ended ~~September 30~~March 31, ~~2010. A total~~2011 ~~increase~~compared to a decrease of $0.2.8 million ~~was recorded~~ during the ~~nine~~same period in 2010 related to reserves for losses in prior years.

Table of Contents

~~months~~The ~~ended~~long-term ~~September~~portion ~~30, 2010. As a result~~ of ~~the~~insurance ~~actuarial valuation~~reserves ~~completed~~was ~~in September 2009, the Company recorded a decrease of~~ $0162.9 0 million inand ~~its provision for insurance liabilities during the three months ended September 30, 2009. A total increase of~~ $4158.3 million ~~was~~as ~~recorded~~of ~~during~~March 31, ~~the~~2011 ~~nine~~and ~~months~~December 31, ~~ended September 30~~2010, ~~2009~~respectively.

The long-term portion of insurance reserves was $155.2 million and $143.6 million as of September 30, 2010 and December 31, 2009, respectively.

Trade and Other Accounts Receivable, net

The Company ~~determines~~estimates its allowances based on payor reimbursement schedules, historical collections and write-off experience and other economic data. The allowances for contractual discounts and uncompensated care are reviewed monthly. Account balances are charged off against the uncompensated care allowance, which relates principally to receivables recorded for self-pay patients, when it is probable the receivable will not be recovered. Write-offs to the contractual allowance occur when payment is received. The ~~allowance for uncompensated care is related principally to receivables recorded for self-pay patients. The~~ Company’s accounts receivable and allowances are as follows:

	September 30, 2010		December 31, 2009
	March 31, 2011		December 31, 2010
Gross trade accounts receivable	$	2,~~068~~257,~~202~~572	$	12,~~955~~119,~~152~~854
Allowance for contractual discounts	1,~~088~~175,~~277~~961		1,~~001~~092,~~285~~188
Allowance for uncompensated care	~~576~~673,~~683~~260		~~572~~629,~~015~~419
Net trade accounts receivable	~~403~~408,~~242~~351		~~381~~398,~~852~~247
Other receivables, net	8996,~~481~~782		7791,~~236~~411
Net accounts receivable	$	~~492~~505,~~723~~133	$	~~459~~489,~~088~~658

Other receivables primarily represent EmCare hospital subsidies and fees and AMR fees for stand-by and special events and subsidies from community organizations.

AMR contractual allowances are determined primarily on payor reimbursement schedules that are included and regularly updated in the billing systems, and by historical collection experience. The billing systems calculate the difference between payor specific gross billings and contractually agreed to, or governmentally driven, reimbursement rates. The allowance for uncompensated care at AMR is related principally to receivables recorded for self-pay patients. AMR’s allowances on self-pay accounts receivable are estimated on claim level, historical write-off experience.

Accounts receivable allowances at EmCare are estimated based on cash collection and write-off experience at a facility level contract and facility specific payor mix. These allowances are reviewed and adjusted monthly through revenue provisions. In addition, a look-back analysis is done, typically after 15 months, to compare actual cash collected on a date of service basis to the revenue recorded for that period. Any adjustment necessary for an overage or deficit in these allowances based on actual collections is recorded through a revenue adjustment in the current period.

Revenue Recognition

Revenue is recognized at the time of service and is recorded net of provisions for contractual discounts and estimated uncompensated care. Provisions for ~~estimated~~ contractual discounts are related principally to differences between gross charges and specific payor, including governmental, reimbursement schedules. Provisions for estimated uncompensated care are related principally to the number of self-pay patients treated in the period. Provisions for contractual discounts and estimated uncompensated care as a percentage of gross revenue and as a percentage of gross revenue less provision for contractual discounts are as follows:

	Quarter ended September 30,				Nine months ended September 30,
	Quarter ended March 31,
	2010		2009		2010		2009
	2011		2010
Gross revenue	100.0	%	100.0	%	~~100.0~~	%	~~100.0~~	%
Provision for contractual discounts	5253.35	%	4952.21	%	~~52.5~~	%	~~48.9~~	%
Revenue net of contractual discounts	4746.75	%	5047.89	%	~~47.5~~	%	~~51.1~~	%
Provision for uncompensated care as a percentage of gross revenue	1918.08	%	2018.38	%	~~18.7~~	%	~~20.1~~	%
Provision for uncompensated care as a percentage of gross revenue less contractual discounts	3940.95	%	39.92	%	~~39.3~~	%	~~39.3~~	%

Healthcare reimbursement is complex and may involve lengthy delays. Third-party payors are continuing their efforts to control expenditures for healthcare, including proposals to revise reimbursement policies. The Company has from time to time experienced delays in reimbursement from third-party payors. In addition, third-party payors may disallow, in whole or in part, claims for payment based on determinations that certain amounts are not reimbursable under plan coverage, determinations of medical necessity, or the need for additional information. Laws and regulations governing the Medicare

Table of Contents

~~Healthcare reimbursement is complex~~ and may involve lengthy delays. Third-party payors are continuing their efforts to control expenditures for healthcare, including proposals to revise reimbursement policies. The Company has from time to time experienced delays in reimbursement from third-party payors. In addition, third-party payors may disallow, in whole or in part, claims for reimbursement based on determinations that certain amounts are not reimbursable under plan coverage, determinations of medical necessity, or the need for additional information. Laws and regulations governing the Medicare and Medicaid programs are very complex and subject to interpretation. Revenue is recognized on an estimated basis in the period in which related services are rendered. As a result, there is a reasonable possibility that recorded estimates will change materially in the short-term. Such amounts, including adjustments between provisions for contractual discounts and uncompensated care, are adjusted in future periods, as adjustments become known. These adjustments were less than 1% of net revenue for the three ~~and~~ ~~nine~~ month periods ~~ending~~ended ~~September 30~~March 31, ~~2010~~2011 and ~~2009~~2010.

The Company also provides services to patients who have no insurance or other third-party payor coverage. In certain circumstances, federal law requires providers to render services to any patient who requires ~~emergency~~ care regardless of their ability to pay. Services to these patients are not considered to be charity care.

Equity Structure

On December 21, 2005, the Company effected a reorganization and issued 8.1 million shares of class A common stock in an initial public offering. Pursuant to the reorganization, EMS LP, the former top-tier holding company of AMR and EmCare, became the consolidated subsidiary of EMSC, a newly formed corporation. To effect the reorganization, the holders of the capital stock of the sole general partner of EMS LP contributed that capital stock to the Company in exchange for class B common stock; the general partner was merged into the Company and the Company became the sole general partner of EMS LP. Concurrently, the holders of class B units of EMS LP contributed their units to the Company in exchange for shares of the Company’s class A common stock, and the holders of certain class A units of EMS LP contributed their units to the Company in exchange for shares of the Company’s class B common stock.

As of ~~September 30~~March 31, ~~2010~~2011, the Company holds 68.89% of the equity interests in EMS LP. LP exchangeable units, held by persons affiliated with the Company’s principal equity holder, represent the balance of the EMS LP equity. The LP exchangeable units are exchangeable at any time, at the option of the holder, for shares of the Company’s class B common stock on a one-for-one basis. The holders of the LP exchangeable units have the right to vote, through the trustee holder of the Company’s class B special voting stock, at all stockholder meetings at which holders of the Company’s class B common stock or class B special voting stock are entitled to vote.

In the EMS LP partnership agreement, the Company has agreed to maintain the economic equivalency of the LP exchangeable units and the class B common stock, and the holders of the LP exchangeable units have no general voting rights. The LP exchangeable units, when considered with the class B special voting stock, have the same rights, privileges and characteristics of the Company’s class B common stock. The LP exchangeable units are intended to be economically equivalent to the class B common stock of the Company in that the LP exchangeable units carry the right to vote (by virtue of the class B special voting stock) with the holders of class B common stock as one class, and entitle holders to receive distributions only if the equivalent dividends are declared on the Company’s class B common stock. Accordingly, the Company accounts for the LP exchangeable units as if the LP exchangeable units were shares of its common stock, including reporting the LP exchangeable units in the equity section of the Company’s balance sheet and including the number of outstanding LP exchangeable units in both its basic and diluted earnings per share calculations.

Fair Value Measurement

The Company classifies its financial instruments that are reported at fair value based on a hierarchal framework which ranks the level of market price observability used in measuring financial instruments at fair value. Market price observability is impacted by a number of factors, including the type of instrument and the characteristics specific to the instrument. Instruments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Financial instruments measured and reported at fair value are classified and disclosed in one of the following categories:

Level 1 — Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. The Company does not adjust the quoted price for these assets or liabilities.

Level 2 — Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies. Balances in this category include mortgage backed securities, corporate bonds, and derivatives.

Level 3 — Pricing inputs are unobservable as of the reporting date and reflect the Company’s own assumptions about the fair value of the asset or liability.

Table of Contents

~~fair~~The ~~value~~following table summarizes the valuation of EMSC’s financial instruments by the ~~asset~~above ~~or liability.~~fair value hierarchy levels as of March 31, 2011:

The following table summarizes the valuation of EMSC’s financial instruments by the above fair value hierarchy levels as of September 30, 2010:

Description	Total		Level 1		Level 2		Level 3
Assets:
Securities	$	116,851	$	101,032	$	15,819	$	—
Derivatives	$	3,338	$	—	$	3,338	$	—
Liabilities:
Contingent consideration	$	18,096	$	—	$	—	$	18,096

Description	Total		Level 1		Level 2		Level 3
Assets:
Securities	$	62,152	$	49,608	$	12,544	$	—
Derivatives	$	571	$	—	$	571	$	—

The contingent consideration balance classified as a level 3 liability decreased by $2.2 million since December 31, 2010 due to payments made by the Company during the three months ended March 31, 2011.

Recent Accounting Pronouncements

In ~~August~~ August 2010, the Financial Accounting Standards Board (“FASB”) further defined the requirements for measurement and disclosure of charity care provided. The amendments require that cost, both direct and indirect, be used as the measurement basis for charity care disclosure purposes. These amendments ~~will~~were be effective for the Company beginning January 1, 2011. ~~Management~~ Adoption ~~does not expect the adoption~~ of this guidance todid not have a material effect on the Company’s consolidated financial statements and related disclosures.

Also in August 2010, the FASB clarified that healthcare entities should not net insurance recoveries against a related claim liability. These amendments ~~will~~were be effective for the Company beginning January 1, 2011. ~~Management~~ Adoption ~~does not expect the adoption~~ of this guidance todid not have a material effect on the Company’s consolidated financial statements and related disclosures.

3. Acquisitions

~~During~~ On January 11, 2011, the ~~three~~Company ~~months~~completed ~~ended~~the ~~March~~acquisition ~~31,~~of ~~2010,~~Northwood ~~the~~Anesthesia ~~Company~~Associates, ~~made~~and aan ~~purchase~~affiliate ~~price allocation~~of ~~adjustment~~the ~~related~~Company tocompleted the acquisition of the ~~management~~related ~~services~~ professional entity, ofNorth ~~Pinnacle~~Pinellas Anesthesia ~~Consultants~~Associates (collectively referred to as “North Pinellas”), ~~P.A.~~an ~~and~~anesthesia ~~Pinnacle~~provider ~~Consultants Mid-Atlantic~~based in Tampa, LFlorida.~~L.C.~~ On ~~(together~~February 17, 2011, the ~~Pinnacle~~Company ~~Acquisition”)~~completed the acquisition of Doctor’s Ambulance Service, which ~~closed~~provides emergency and non-emergency ambulance services in ~~December~~ ~~2009~~Orange County, California. ~~Based~~The ontotal ancost ~~independent valuation~~of ~~analysis~~these ~~completed~~acquisitions ~~during~~was ~~the~~$30.2 ~~first~~million ~~quarter~~and ofthe ~~2010,~~Company has recorded $3124.12 million ~~was~~ ~~reclassified~~of ~~from~~ goodwill, which amount is subject to ~~intangible~~adjustment ~~assets,~~based ~~and~~upon ~~amortized~~completion ~~accordingly~~of purchase price allocations.

On May 28, 2010, the Company completed the acquisition of V.I.P. Professional Services, Inc., the parent of Gold Coast Ambulance Service, which provides emergency and non-emergency ambulance services in southwest Ventura County, California. On June 4, 2010, an affiliate of the Company completed the acquisition of professional entities which provide anesthesiology services for Clinical Partners Management Company, an existing subsidiary of the Company. On June 30, 2010, the Company completed its acquisition of Affilion, Inc., which provides emergency department physician staffing and related management services to hospitals in Arizona, New Mexico and Texas. Also on June 30, 2010, an affiliate of the Company completed its acquisition of Fredericksburg Anesthesia Consultants, PLLC, a provider of anesthesia services to facilities in south Texas. The total cost of these and other smaller acquisitions was $51.2 million and the Company has recorded $35.7 million of goodwill, which amount is subject to adjustment based upon completion of purchase price allocations.

4. Accrued Liabilities

Accrued liabilities were as follows at ~~September 30~~March 31, ~~2010~~2011 and December 31, ~~2009~~2010:

	September 30, 2010		December 31, 2009
	March 31,		December 31,
Accrued wages and benefits	$	113,355	$	92,721
	2011		2010
Accrued paid time-off	27,422		24,290
Accrued wages and benefits	$	118,088	$	103,238
Current portion of self-insurance reserves	53,593		62,832
Accrued paid time-off	27,372		24,420
Accrued restructuring	165		181
Current portion of self-insurance reserves	48,890		50,064
Current portion of compliance and legal	7,253		2,814
Accrued restructuring	155		160
Accrued billing and collection fees	3,800		4,093
Current portion of compliance and legal	7,323		5,929
Accrued incentive compensation	20,253		34,000
Accrued billing and collection fees	3,756		3,500
Accrued interest	1,003		9,773
Accrued incentive compensation	13,916		21,446
Accrued income taxes payable	—		5,454
Accrued interest	841		979
Other	37,759		37,546
Accrued income taxes payable	17,644		—
Total accrued liabilities	$	264,603	$	273,704
Other	49,794		49,902
Total accrued liabilities	$	287,779	$	259,638

5. Long-Term Debt

Long-term debt consisted of the following at March 31, 2011 and December 31, 2010:

Table of Contents

5. Long-Term Debt

	March 31, 2011			December 31, 2010
Senior secured term loan due 2015 (3.27% at March 31, 2011)	$	417,031		$	419,688
Notes due at various dates from 2011 to 2022 with interest rates from 6% to 10%	1,566			832
Capital lease obligations due at various dates from 2011 to 2018	713			756
	419,310			421,276
Less current portion	(19,723		)	(16,333		)
Total long-term debt	$	399,587		$	404,943

On April 8, 2010, the Company completed the financing of new senior secured credit facilities consisting of a $425 million term loan and a $150 million revolving credit facility. The term loan bears interest at LIBOR, plus a margin of 3.00%, and requires quarterly principal repayments until maturity in 2015. The revolving facility bears interest at LIBOR, plus a margin of 3.00%, and is repayable at maturity in 2015. The senior secured credit facilities can be expanded and the interest rate margins stepped down to 2.75% upon achieving certain leverage ratios. Substantially all of EMS LP’s domestic assets are pledged as collateral under the new senior secured credit facilities. The revolving facility is also subject to an annual commitment fee of 0.5% on unutilized commitments.

In conjunction with completing the financing under the new credit facilities, the Company repaid the balance outstanding on the previous senior secured term loan and redeemed the Company’s 10% senior subordinated notes. During the three months ended June 30, 2010, the Company recorded a loss on early debt extinguishment of $19.1 million which included certain unamortized debt issuance costs as well as costs associated with the redemption of the senior subordinated notes.

Long-term debt consisted of the following at September 30, 2010 and December 31, 2009:

	September 30, 2010			December 31, 2009
Senior subordinated notes	$	—		$	250,000
Senior secured term loan due 2015 (3.28% at September 30, 2010)	422,344			199,765
Notes due at various dates from 2010 to 2022 with interest rates from 6% to 10%	1,115			1,249
Capital lease obligations due at various dates from 2010 to 2018 (see note 7)	801			2,916
	424,260			453,930
Less current portion	(13,953		)	(4,676		)
Total long-term debt	$	410,307		$	449,254

6. Derivative Instruments and Hedging Activities

The Company manages its exposure to changes in ~~market interest rates and~~ fuel prices and, from time to time, uses highly effective derivative instruments to manage well-defined risk exposures. The Company monitors its positions and the credit ratings of its counterparties and does not anticipate non-performance by the counterparties. The Company does not use derivative instruments for speculative purposes.

At ~~September~~ 30March 31, ~~2010~~2011, the Company was party to a series of fuel hedge transactions with a major financial institution under one master agreement. Each of the transactions effectively fixes the cost of diesel fuel at prices ranging from $3.0007 to $3.29 per gallon. The Company purchases the diesel fuel at the market rate and periodically settles with its counterparty for the difference between the national average price for the period published by the Department of Energy and the agreed upon fixed price. The transactions fix the price for a total of 53.9 million gallons, which ~~represent~~represents approximately 32 29% of the Company’s total estimated ~~usage~~annual ~~over the hedge period~~usage, and are spread over periods from ~~October~~April 2011 ~~2010~~ through June 2012. As of ~~September 30~~March 31, ~~2010~~2011, the Company recorded, as a component of other comprehensive income before applicable tax impacts, an asset associated with the fair value of the fuel hedge in the amount of $03.6 3 million, compared to $01.27 million as of December 31, ~~2009~~2010. Settlement ~~The~~of ~~net~~hedge ~~additional payments~~agreements ~~made~~during orthe ~~received~~three ~~under~~months ~~these~~ended ~~hedge~~March 31, ~~agreements~~2011 ~~did~~resulted ~~not~~in ~~have~~ a ~~material impact~~reduction onin operating expenses of $0.6 million compared to an increase in operating expenses of less than $0.1 million for transactions settled during the ~~nine~~three months ended ~~September 30~~March 31, 2010.

7. Commitments and Contingencies

Lease Commitments

The Company leases various facilities and equipment under operating lease agreements.

The Company also leases certain leasehold improvements under capital leases. Assets under capital leases are capitalized using inherent interest rates at the inception of each lease. Capital leases are collateralized by the underlying assets.

Purchase Commitment

Beginning in March 2009, AMR entered into a series of forward purchase contracts which fixed the price for a portion of its total monthly diesel fuel usage from April 1, 2009 through June 30, 2010. Based on the terms of the contracts, the Company has concluded they do not qualify as derivatives. There was no material impact to operating expenses related to

Table of Contents

these contracts during the three and nine month periods ended September 30, 2010 and 2009.

Services

The Company is subject to the Medicare and Medicaid fraud and abuse laws which prohibit, among other things, any false claims, or any bribe, kickback or rebate in return for the referral of Medicare and Medicaid patients. Violation of these prohibitions may result in civil and criminal penalties and exclusion from participation in the Medicare and Medicaid programs. Management has implemented policies and procedures that management believes will assure that the Company is in substantial compliance with these laws and regulations but there can be no assurance the Company will not be found to have violated certain of these laws and regulations. From time to time, the Company receives requests for information from government agencies pursuant to their regulatory or investigational authority. Such requests can include subpoenas or demand letters for documents to assist the government agencies in audits or investigations. The Company is cooperating with the government agencies conducting these investigations and is providing requested information to the government agencies. Other than the proceedings described below, management believes that the outcome of any of these investigations would not have a material adverse effect on the Company.

Other Legal Matters

~~On December~~In 13December 2006, ~~2005,~~AMR received a ~~lawsuit~~subpoena ~~purporting~~from tothe beDepartment aof ~~class~~Justice ~~action~~(DOJ). The ~~was~~subpoena ~~commenced against~~requested ~~AMR~~copies inof ~~Spokane,~~documents ~~Washington~~for inthe ~~Washington~~period ~~State~~from ~~Court,~~January 2000 ~~Spokane County~~through the present. The ~~complaint~~subpoena ~~alleged~~required ~~that~~ AMR ~~billed~~to ~~patients~~produce ~~and~~a ~~third~~broad ~~party payors~~range ~~for~~of ~~transports~~documents itrelating ~~conducted~~to ~~between~~the ~~1998~~operations ~~and~~of ~~2005~~certain atAMR ~~higher~~affiliates ~~rates~~in ~~than contractually~~New ~~permitted~~York. The ~~court~~Company ~~has~~produced ~~certified~~documents aresponsive ~~class~~to inthe ~~this~~subpoena. ~~case which~~The isgovernment ~~comprised~~identified ofclaims ~~approximately~~for ~~15,000~~reimbursement ~~Spokane~~that ~~County~~the ~~residents. In~~government ~~September 2010,~~believes lack support for the ~~Company~~level billed, and ~~class~~invited ~~representatives~~the ~~reached~~Company anto ~~agreement~~respond to ~~resolve~~ the ~~claims~~ ~~for~~identified ~~approximately~~areas $1of concern.1 ~~million,~~The ~~which~~Company ~~amount~~reviewed ~~includes~~the ~~all~~information ~~remaining refunds~~provided ~~due~~by tothe ~~class~~government, ~~members~~provided its response, and ~~attorney’s~~is ~~fees~~currently ~~for~~in discussions with the ~~plaintiffs’ counsel. The~~DOJ ~~settlement~~and isthe ~~expected~~Office toof bethe ~~approved~~Inspector General of Health and ~~finalized~~Human byServices regarding resolution of this matter. During the ~~court~~ bysecond quarter of 2010, the ~~end~~Company recorded a $3.1 million reserve for its estimate of ~~January~~likely ~~2011~~exposure in this matter.

In December 2006, AMR received a subpoena from the Department of Justice (DOJ). The subpoena requested copies of documents for the period from January 2000 through the present. The subpoena required AMR to produce a broad range of documents relating to the operations of certain AMR affiliates in New York. The Company produced documents responsive to the subpoena. The government has identified claims for reimbursement that the government believes lack support for the level billed, and invited the Company to respond to the identified areas of concern. The Company reviewed the information provided by the government, provided its response, and is currently in discussions with the DOJ and the Office of the Inspector General of Health and Human Services regarding resolution of this matter. During the three months ended June 30, 2010, the Company recorded a $3.1 million reserve for its estimate of likely exposure in this matter.10

~~Four different~~Table ~~lawsuits purporting to be class actions have been filed against AMR and certain subsidiaries in California alleging violations~~ of California wage and hour laws. On April 16, 2008, Lori Bartoni commenced a suit in the Superior Court for the State of California, County of Alameda; on July 8, 2008, Vaughn Banta filed suit in the Superior Court of the State of California, County of Los Angeles; on January 22, 2009, Laura Karapetian filed suit in the Superior Court of the State of California, County of Los Angeles; and on March 11, 2010, Melanie Aguilar filed suit in the Superior Court of the State of California County of Los Angeles. The Banta and Karapetian cases have been coordinated with the Bartoni case in the Superior Court for the State of California, County of Alameda. At the present time, the courts have not certified classes in any of these cases. Plaintiffs allege principally that the AMR entities failed to pay daily overtime charges pursuant to California law, and failed to provide required meal breaks or pay premium compensation for missed meal breaks. Plaintiffs are seeking to certify the classes and are seeking lost wages, punitive damages, attorneys’ fees and other sanctions permitted under California law for violations of wage hour laws. The Company is unable at this time to estimate the amount of potential damages, if any.Contents

~~The Company~~Four isdifferent ~~involved~~lawsuits inpurporting ~~other~~to ~~litigation~~be ~~arising~~class actions have been filed against AMR and certain subsidiaries in ~~the~~California ~~ordinary~~alleging ~~course~~violations of ~~business~~ California wage and hour laws. ~~Management~~On ~~believes~~April 16, 2008, Lori Bartoni commenced a suit in the ~~outcome~~ Superior Court for the State of ~~these~~California, ~~legal~~County ~~proceedings~~of ~~will~~Alameda; ~~not~~on ~~have~~July a8, ~~material~~2008, ~~adverse~~Vaughn ~~impact~~Banta filed suit in the Superior Court of the State of California, County of Los Angeles; on ~~its~~ ~~financial~~January 22, ~~condition~~2009, ~~results~~Laura Karapetian filed suit in the Superior Court of ~~operations~~the State of California, County of Los Angeles, and on March 11, 2010, Melanie Aguilar filed suit in Superior Court of the State of California, County of Los Angeles. The Banta and Karapetian cases have been coordinated with the Bartoni case in the Superior Court for the State of California, County of Alameda. At the present time, courts have not certified classes in any of these cases. Plaintiffs allege principally that the AMR entities failed to pay overtime charges pursuant to California law, and failed to provide required meal breaks or ~~liquidity~~pay premium compensation for missed meal breaks. Plaintiffs are seeking to certify the classes and are seeking lost wages, punitive damages, attorneys’ fees and other sanctions permitted under California law for violations of wage hour laws. The Company is unable at this time to estimate the amount of potential damages, if any.

Eleven purported shareholder class actions relating to the transactions contemplated by the Merger Agreement described in Note 11 herein have been filed in state court in Delaware and federal and state courts in Colorado against various combinations of the Company, the members of the Company’s board of directors, and other parties. Seven actions were filed in the Delaware Court of Chancery beginning on February 22, 2011, which have since been consolidated into one action entitled In re Emergency Medical Services Corporation Shareholder Litigation, Consolidated C.A. No. 6248-VCS. On April 4, 2011, the Delaware plaintiffs filed their consolidated class action complaint. Two actions, entitled Scott A. Halliday v. Emergency Medical Services Corporation, et al., Case No. 2011CV316 (filed on February 15, 2011), and Alma C. Howell v. William Sanger, et. al., Case No. 2011CV488 (filed on March 1, 2011), were filed in the District Court, Arapahoe County, Colorado. Two other actions, entitled Michael Wooten v. Emergency Medical Services Corporation, et al., Case No. 11-CV-00412 (filed on February 17, 2011) (the “Wooten action”), and Neal Greenberg v. Emergency Medical Services Corporation, et. al., Case No. 11-CV-00496 (filed on February 28, 2011), were filed in the U.S. District Court for the District of Colorado. These actions generally allege that the directors of the Company, Onex Corporation and/or Onex Corporation’s subsidiaries breached their fiduciary duties by, among other things: approving the transactions contemplated by the Merger Agreement, which allegedly were financially unfair to the Company and its public stockholders; agreeing to provisions in the Merger Agreement that will allegedly prevent the board from considering other offers; permitting the unitholders agreement (which secures the majority votes in favor of the Merger) and failing to require a provision in the Merger Agreement requiring that a majority of the public stockholders approve the transactions contemplated by the Merger Agreement; and/or making allegedly materially inadequate disclosures. These actions further allege that certain defendants aided and abetted these breaches. In addition, the two actions filed in the U.S. District Court for the District of Colorado contain individual claims brought under Section 14(a) and Section 20(a) of the Securities Exchange Act of 1934, as amended, pertaining to the purported dissemination of allegedly misleading proxy materials. These actions seek unspecified damages and equitable relief, including an injunction halting the Merger or rescission of the Merger, as applicable. The plaintiffs in the consolidated Delaware action have filed a motion for a preliminary injunction. The Company believes that all of the allegations in these actions are without merit and intends to vigorously defend these matters. If any one of the plaintiffs is successful in obtaining an injunction prohibiting the completion of the Merger on the agreed-upon terms, then such injunction may prevent the Merger from becoming effective, or from becoming effective within the expected timeframe.

The Company is involved in other litigation arising in the ordinary course of business. Management believes the outcome of these legal proceedings will not have a material adverse effect on its financial condition, results of operations or liquidity.

8. Equity Based Compensation

The Company’s stock options are valued using the Black-Scholes valuation ~~model~~method on the date of grant. Equity based compensation has been issued under the plans described below.

~~Equity Option~~Long-Term Incentive Plan

~~Under the~~The Company’s ~~Equity~~original ~~Option~~2007 Long-Term Incentive Plan, ~~key~~was ~~employees~~approved ~~were~~by ~~granted~~stockholders ~~options~~in ~~that permit~~May 2007 and a Second Amended and Restated 2007 Long-Term Incentive Plan (the ~~individuals~~“Plan”) was approved by stockholders in May 2010. The Plan provides for the grant of long-term incentives, including various equity-based incentives, to ~~purchase~~those ~~class~~persons Awith ~~common~~responsibility ~~shares~~for the success and growth of the Company and its subsidiaries. Options granted under the Plan vest and become exercisable ratably ~~generally~~ over a period of four years. from the date of grant and have a maximum term of ten years. In addition, for options granted under the Plan prior to January 1, 2009, certain performance measures must be met for 50% of ~~the~~certain of these options to become exercisable; these performance measures were satisfied during ~~2009~~the first quarter of 2010. The Company also grants shares of restricted stock under the Plan, which currently lapse ratably over a period of three years from the date of grant. In addition, with respect to grants of restricted stock to the Company’s “named executive officers” and persons deemed “covered employees” under section 162(m) of the Internal Revenue Code of 1986, as amended, certain profitability-based performance measures must be met within that three-year period for restricted stock grants to vest.

Table of Contents

~~the~~The ~~options granted under the Equity Option Plan. As the vesting period for these options was completed prior to 2010, the~~ Company ~~did~~recorded ~~not record~~ a compensation charge ~~during each~~ of ~~the~~ ~~three~~$1,762 and ~~nine~~$979 ~~months ended September 30, 2010 as well as~~ during the three months ended ~~September 30~~March 31, ~~2009. A compensation~~2011 ~~charge~~and ~~of $97 was recorded for the nine months ended September 30~~2010, ~~2009. Options~~ ~~are no longer granted under the Equity Option Plan~~respectively, ~~but~~in ~~rather~~connection ~~under~~with the ~~Company’s Second Amended and Restated Long-Term Incentive~~ Plan ~~described below~~.

Long-Term Incentive Plan

The Company’s original 2007 Long-Term Incentive Plan was approved by stockholders in May 2007, amended and restated in May 2008, and a Second Amended and Restated Long-Term Incentive Plan (the “Plan”) was approved by stockholders in May 2010. The Plan provides for the grant of long-term incentives, including various equity-based incentives, to those persons with responsibility for the success and growth of the Company and its subsidiaries. Options granted under the Plan vest and become exercisable ratably over a period of four years from the date of grant and have a maximum term of ten years. In addition, for options granted under the Plan prior to January 1, 2009, certain performance measures were required to be met for 50% of these options to become exercisable; these performance measures were satisfied during the first quarter of 2010. The Company also grants shares of restricted stock under the Plan, which currently lapse ratably over a period of three years from the date of grant. In addition, with respect to grants of restricted stock in May 2010 to the Company’s “named executive officers” and persons deemed “covered employees” under section 162(m) of the Internal Revenue Code of 1986, as amended, certain profitability-based performance measures must be met within that three-year period for restricted stock grants to lapse.

The Company recorded a compensation charge of $1,859 and $996 during the three months ended September 30, 2010 and 2009, respectively, and $4,135 and $2,403 during the nine months ended September 30, 2010 and 2009, respectively, in connection with the Plan.

Non-Employee Director Compensation Plan

The Non-Employee Director Compensation Plan, approved in May 2007, is available to non-employee directors of the Company, other than the Chair of the Compliance Committee. Under this plan, eligible directors are granted ~~Restricted~~restricted ~~Stock~~stock ~~Units~~units (“RSUs”) following each annual stockholder meeting with each RSU representing one share of the Company’s class A common stock. AsEligible ~~of May 2010, eligible~~ directors ~~now~~ receive a grant of RSUs having a fair market value of $133 on the date of grant based on the closing price of the Company’s class A common stock on the business day immediately preceding the grant date. The Non-Employee Director Compensation Plan allows directors to defer income from the grant of RSUs, which vest immediately prior to the election of directors at the next annual stockholder meeting. In connection with this plan, the Company granted 2,324 RSUs per director ~~after~~following the ~~Company’s~~ 2010 annual stockholder meeting, ~~plus~~and granted an additional ~~prorated amount of~~ 1,854 RSUs to a director upon his election to the board of directors in July 2010. ~~The~~As ~~Company~~the ~~granted~~2011 ~~3,018~~annual ~~RSUs~~stockholder ~~per~~meeting ~~director in~~has ~~2009. The~~not ~~Company~~been ~~expensed~~held ~~$183~~as ~~and $125~~of ~~during~~March 31, ~~the~~2011, ~~three~~there ~~month~~have ~~periods~~been ~~ended~~no ~~September 30,~~RSUs ~~2010~~granted ~~and~~to ~~2009, respectively,~~date ~~and~~in 2011. The Company expensed $~~452~~200 and $~~375~~125 during the ~~nine~~three ~~month~~months ~~periods~~ ended ~~September~~March 3031, ~~2010~~ 2011 and ~~2009~~2010, respectively.

Stock Purchase Plan/Employee Stock Purchase Plan

During the second quarter of 2010, the Company commenced an offering of its class A common stock to eligible employees and independent contractors associated with the Company and its subsidiaries pursuant to the Company’s Stock Purchase Plan and Employee Stock Purchase Plan (together, the “SPPs”). The purchases of stock under the SPPs occurred in October 2010 at a 5% discount to the closing price of the Company’s class A common stock on October 15, 2010, and as such no compensation charge was recorded for these plans during the nine months ended September 30, 2010.

9. Segment Information

The Company is organized around two separately managed business units: ~~healthcare~~medical transportation services and facility-based physician services, which have been identified as operating segments. The ~~healthcare~~medical transportation services reportable segment focuses on providing a full range of medical transportation services from basic patient transit to the most advanced emergency care and pre-hospital assistance. The facility-based physician services reportable segment provides physician services to hospitals primarily for emergency departments and urgent care centers, as well as for hospitalist/ inpatient, radiology, teleradiology and anesthesiology services. The Chief Executive Officer has been identified as the chief operating decision maker (“CODM”) as he assesses the performance of the business units and decides how to allocate resources to the business units.

Net income before equity in earnings of unconsolidated subsidiary, income tax expense, ~~loss on early debt extinguishment,~~ interest and other (expense) income, realized (loss) gain on investments, interest expense, and depreciation and amortization expense (“Adjusted EBITDA”) is the measure of profit and loss that the CODM uses to assess performance, measure liquidity and make decisions. The accounting policies for reported segments are the same as for the Company as a whole.

	Quarter ended March 31,
	2011			2010
Medical Transportation Services
Net revenue	$	364,208		$	336,962
Segment Adjusted EBITDA	35,589			32,402
Facility-Based Physician Services
Net revenue	396,627			342,392
Segment Adjusted EBITDA	47,228			42,033
Total
Total net revenue	760,835			679,354
Total Adjusted EBITDA	82,817			74,435
Reconciliation of Adjusted EBITDA to Net Income
Adjusted EBITDA	$	82,817		$	74,435
Depreciation and amortization expense	(17,525		)	(16,180		)
Interest expense	(4,817		)	(8,266		)
Realized (loss) gain on investments	(4		)	92
Interest and other (expense) income	(1,746		)	265
Income tax expense	(22,652		)	(19,410		)
Equity in earnings of unconsolidated subsidiary	91			94
Net income	$	36,164		$	31,030

Table of Contents

EBITDA”) is the measure of profit and loss that the CODM uses to assess performance, measure liquidity and make decisions. The accounting policies for reported segments are the same as for the Company as a whole.

	Quarter ended September 30,						Nine months ended September 30,
	2010			2009			2010			2009
Healthcare Transportation Services
Net Revenue	$	352,226		$	338,768		$	1,033,347		$	1,010,718
Segment Adjusted EBITDA	31,449			31,838			95,611			98,151
Facility-Based Physician Services
Net Revenue	384,954			326,288			1,091,991			904,651
Segment Adjusted EBITDA	48,627			40,449			137,294			112,652
Total
Total Net Revenue	737,180			665,056			2,125,338			1,915,369
Total Adjusted EBITDA	80,076			72,287			232,905			210,803
Reconciliation of Adjusted EBITDA to Net Income
Adjusted EBITDA	$	80,076		$	72,287		$	232,905		$	210,803
Depreciation and amortization expense	(16,528		)	(15,733		)	(48,400		)	(48,658		)
Interest expense	(4,856		)	(10,280		)	(18,182		)	(30,749		)
Realized gain on investments	730			544			879			2,030
Interest and other income	277			502			748			1,442
Loss on early debt extinguishment	—			—			(19,091		)	—
Income tax expense	(22,990		)	(18,533		)	(57,355		)	(53,144		)
Equity in earnings of unconsolidated subsidiary	53			91			252			244
Net income	$	36,762		$	28,878		$	91,756		$	81,968

A reconciliation of Adjusted EBITDA to cash flows provided by operating activities is as follows:

	Quarter ended September 30,						Nine months ended September 30,
	Quarter ended March 31,
	2010			2009			2010			2009
	2011			2010
Adjusted EBITDA	$	8082,~~076~~817		$	7274,~~287~~435		$	~~232,905~~		$	~~210,803~~
Interest paid	(4,195		)	(9,773		)	(16,385		)	(29,424		)
Interest expense (less deferred loan fee amortization)	(4,017		)	(7,759		)
Change in accounts receivable	(10,~~882~~762		)	72,~~574~~191			~~(30,441~~		)	~~8,448~~
Change in other operating assets/liabilities	1126,~~164~~769			(23,~~956~~934		)	~~18,192~~			~~16,000~~
Equity based compensation	21,~~042~~962			1,~~121~~104			~~4,587~~			~~2,875~~
Excess tax benefits from stock-based compensation	(~~479~~1,169		)	—(10,581		)	~~(13,977~~		)	—
Income tax expense, net of change in deferred taxes	(2422,~~092~~307		)	(~~472~~19,543		)	~~(57,617~~		)	~~(3,155~~		)
Other	~~989~~(1,294		)	~~1,081~~804			~~2,101~~			~~4,254~~
Cash flows provided by operating activities	$	5471,~~623~~999		$	6844,~~862~~585		$	~~139,365~~		$	~~209,801~~

10. Guarantors of Debt

EMS LP’s wholly-owned subsidiaries, AMR HoldCo, Inc. and EmCare HoldCo, Inc., are the borrowers under the senior secured credit facility, which includes a full, unconditional and joint and several guarantee by EMSC, EMS LP and EMSC’s domestic subsidiaries. The senior secured credit facility does not include a guarantee by the Company’s captive insurance subsidiary and only limited guarantees from any future non-domestic subsidiaries. All of the operating income and cash flow of EMSC, EMS LP, AMR HoldCo, Inc. and EmCare HoldCo, Inc. is generated by AMR, EmCare and their subsidiaries. As a result, funds necessary to meet the debt service obligations under the senior secured credit facility are provided by the distributions or advances from the subsidiary companies, AMR and EmCare. Investments in subsidiary operating companies are accounted for on the equity method. Accordingly, entries necessary to consolidate EMSC, EMS LP, AMR HoldCo, Inc., EmCare HoldCo, Inc. and all of their subsidiaries are reflected in the Eliminations/Adjustments column. Separate complete financial statements of the borrowers, EMS LP and subsidiary guarantors would not provide additional material information that would be useful in assessing the financial composition of the borrowers, EMS LP or the subsidiary guarantors. The condensed consolidating financial statements for EMSC,EMS LP, the borrowers, the guarantors and the non-guarantor are as follows:

Consolidating Statement of Operations

For the quarter ended March 31, 2011

					Issuer		Issuer
					AMR		EmCare		Subsidiary			Subsidiary			Eliminations/
	EMSC		EMS LP		HoldCo, Inc.		HoldCo, Inc.		Guarantors			Non-Guarantor			Adjustments			Total
Net revenue	$	—	$	—	$	—	$	—	$	760,835		$	17,990		$	(17,990	)	$	760,835
Compensation and benefits	—		—		—		—		537,077			—			—			537,077
Operating expenses	—		—		—		—		96,963			—			—			96,963
Insurance expense	—		—		—		—		26,378			18,151			(17,990		)	26,539
Selling, general and administrative expenses	—		—		—		—		17,835			—			—			17,835
Depreciation and amortization expense	—		—		—		—		17,525			—			—			17,525
Income (loss) from operations	—		—		—		—		65,057			(161		)	—			64,896
Interest income from restricted assets	—		—		—		—		231			165			—			396
Interest expense	—		—		—		—		(4,817		)	—			—			(4,817		)
Realized loss on investments	—		—		—		—		—			(4		)	—			(4		)
Interest and other (expense) income	—		—		—		—		(1,746		)	—			—			(1,746		)
Income before income taxes	—		—		—		—		58,725			—			—			58,725
Income tax expense	—		—		—		—		(22,652		)	—			—			(22,652		)
Income before equity in earnings of unconsolidated subsidiaries	—		—		—		—		36,073			—			—			36,073
Equity in earnings of unconsolidated subsidiaries	36,164		36,164		12,208		23,956		91			—			(108,492		)	91
Net income	$	36,164	$	36,164	$	12,208	$	23,956	$	36,164		$	—		$	(108,492	)	$	36,164

Table of Contents

Consolidating Statement of Operations

For the quarter ended ~~September 30~~March 31, 2010

					Issuer		Issuer
					AMR		EmCare		Subsidiary			Subsidiary			Eliminations/
	EMSC		EMS LP		HoldCo, Inc.		HoldCo, Inc.		Guarantors			Non-Guarantor			Adjustments			Total
Net revenue	$	—	$	—	$	—	$	—	$	~~737~~679,~~180~~354		$	197,~~164~~238		$	(197,~~164~~238	)	$	~~737~~679,~~180~~354
Compensation and benefits	—		—		—		—		~~523~~480,~~263~~317			—			—			~~523~~480,~~263~~317
Operating expenses	—		—		—		—		9186,~~023~~529			—			—			9186,~~023~~529
Insurance expense	—		—		—		—		2421,~~586~~467			207,~~371~~841			(197,~~164~~238		)	2522,~~793~~070
Selling, general and administrative expenses	—		—		—		—		1716,~~742~~858			—			—			1716,~~742~~858
Depreciation and amortization expense	—		—		—		—		16,~~528~~180			—			—			16,~~528~~180
Income (loss) from operations	—		—		—		—		6458,~~038~~003			(~~1,207~~603		)	—			6257,~~831~~400
Interest income from restricted assets	—		—		—		—		~~240~~344			~~477~~511			—			~~717~~855
Interest expense	—		—		—		—		(48,~~856~~266		)	—			—			(48,~~856~~266		)
Realized gain on investments	—		—		—		—		—			~~730~~92			—			~~730~~92
Interest and other income	—		—		—		—		~~277~~265			—			—			~~277~~265
Income before income taxes	—		—		—		—		5950,~~699~~346			—			—			5950,~~699~~346
Income tax expense	—		—		—		—		(2219,~~990~~410		)	—			—			(2219,~~990~~410		)
Income before equity in earnings of unconsolidated subsidiaries	—		—		—		—		3630,~~709~~936			—			—			3630,~~709~~936
Equity in earnings of unconsolidated subsidiaries	3631,~~762~~030		3631,~~762~~030		10,~~567~~285		2620,~~195~~744		5394			—			(~~110~~93,~~286~~089		)	5394
Net income	$	3631,~~762~~030	$	3631,~~762~~030	$	10,~~567~~285	$	2620,~~195~~744	$	3631,~~762~~030		$	—		$	(~~110~~93,~~286~~089	)	$	3631,~~762~~030

Consolidating ~~Statement~~Balance ~~of Operations~~Sheet

~~For~~As ~~the~~of ~~quarter ended September 30~~March 31, ~~2009~~2011

						Issuer		Issuer
						AMR		EmCare		Subsidiary			Subsidiary			Eliminations/
	EMSC			EMS LP		HoldCo, Inc.		HoldCo, Inc.		Guarantors			Non-Guarantor			Adjustments			Total
Net revenue	$	—		$	—	$	—	$	—	$	665,056		$	7,226		$	(7,226	)	$	665,056
Assets
Compensation and benefits	—			—		—		—		467,625			—			—			467,625
Current assets:
Operating expenses	—			—		—		—		85,510			—			—			85,510
Cash and cash equivalents	$	—		$	—	$	—	$	—	$	309,558		$	25,214		$	—		$	334,772
Insurance expense	—			—		—		—		23,714			8,357			(7,226		)	24,845
Insurance collateral	—			—		—		—		6,040			10,473			7,986			24,499
Selling, general and administrative expenses	—			—		—		—		15,871			—			—			15,871
Trade and other accounts receivable, net	—			—		—		—		504,793			340			—			505,133
Depreciation and amortization expense	—			—		—		—		15,733			—			—			15,733
Parts and supplies inventory	—			—		—		—		23,332			—			—			23,332
Income (loss) from operations	—			—		—		—		56,603			(1,131		)	—			55,472
Prepaids and other current assets	—			—		—		—		24,593			23			(230		)	24,386
Interest income from restricted assets	—			—		—		—		495			587			—			1,082
Current deferred tax assets	—			—		—		—		(4,111		)	4,111			—			—
Interest expense	—			—		—		—		(10,280		)	—			—			(10,280		)
Current assets	—			—		—		—		864,205			40,161			7,756			912,122
Realized gain on investments	—			—		—		—		—			544			—			544
Non-current assets:
Interest and other income	—			—		—		—		502			—			—			502
Property, plant, and equipment, net	—			—		—		—		139,346			—			—			139,346
Income before income taxes	—			—		—		—		47,320			—			—			47,320
Intercompany receivable	—			—		282,161		126,833		—			—			(408,994		)	—
Income tax expense	—			—		—		—		(18,533		)	—			—			(18,533		)
Intangible assets, net	—			—		—		—		173,714			—			—			173,714
Income before equity in earnings of unconsolidated subsidiaries	—			—		—		—		28,787			—			—			28,787
Non-current deferred tax assets	—			—		—		—		4,126			(6,120		)	1,994			—
Equity in earnings of unconsolidated subsidiaries	28,878			28,878		8,409		20,469		91			—			(86,634		)	91
Insurance collateral	—			—		—		—		26,225			115,081			(8,043		)	133,263
Net income	$	28,878		$	28,878	$	8,409	$	20,469	$	28,878		$	—		$	(86,634	)	$	28,878
Goodwill	—			—		—		—		453,462			458			—			453,920
Other long-term assets	—			—		7,282		3,271		7,064			—			—			17,617
Investment and advances in subsidiaries	887,361			887,361		462,756		422,931		33,206			—			(2,693,615		)	—
Assets	$	887,361		$	887,361	$	752,199	$	553,035	$	1,701,348		$	149,580		$	(3,100,902	)	$	1,829,982
Liabilities and Equity
Current liabilities:
Accounts payable	$	—		$	—	$	—	$	—	$	49,181		$	128		$	—		$	49,309
Accrued liabilities	—			—		645		196		258,586			28,352			—			287,779
Current deferred tax liabilities	—			—		—		—		5,614			—			—			5,614
Current portion of long-term debt	—			—		12,830		5,764		1,129			—			—			19,723
Current liabilities	—			—		13,475		5,960		314,510			28,480			—			362,425
Long-term debt	—			—		274,922		123,516		1,149			—			—			399,587
Long-term deferred tax liabilities	—			—		—		—		5,971			—			—			5,971
Insurance reserves and other long-term liabilities	—			—		—		—		93,861			79,070			1,707			174,638
Intercompany payable	—			—		—		—		400,170			8,824			(408,994		)	—
Liabilities	—			—		288,397		129,476		815,661			116,374			(407,287		)	942,621
Equity:
Class A common stock	305			—		—		—		—			30			(30		)	305
Class B common stock	1			—		—		—		—			—			—			1
Partnership equity	90,776			397,034		322,770		74,264		393,858			—			(1,187,926		)	90,776
Treasury stock at cost	(2,987		)	—		—		—		—			—			—			(2,987		)
Additional paid-in capital	308,939			—		—		—		—			4,316			(4,316		)	308,939
Retained earnings	486,930			486,930		138,632		348,298		488,432			26,522			(1,488,814		)	486,930
Comprehensive income	3,397			3,397		2,400		997		3,397			2,338			(12,529		)	3,397
Equity	887,361			887,361		463,802		423,559		885,687			33,206			(2,693,615		)	887,361
Liabilities and Equity	$	887,361		$	887,361	$	752,199	$	553,035	$	1,701,348		$	149,580		$	(3,100,902	)	$	1,829,982

Table of Contents

Consolidating ~~Statement~~Balance ~~of Operations~~Sheet

~~For~~As ~~the~~of ~~nine months ended September 30~~December 31, 2010

						Issuer		Issuer
						AMR		EmCare		Subsidiary			Subsidiary			Eliminations/
	EMSC			EMS LP		HoldCo, Inc.		HoldCo, Inc.		Guarantors			Non-Guarantor			Adjustments			Total
Net revenue	$	—		$	—	$	—	$	—	$	2,125,338		$	45,265		$	(45,265	)	$	2,125,338
Assets
Compensation and benefits	—			—		—		—		1,500,023			—			—			1,500,023
Current assets:
Operating expenses	—			—		—		—		268,138			—			—			268,138
Cash and cash equivalents	$	—		$	—	$	—	$	—	$	265,761		$	21,600		$	—		$	287,361
Insurance expense	—			—		—		—		71,423			47,647			(45,265		)	73,805
Insurance collateral	—			—		—		—		6,409			30,046			(2,979		)	33,476
Selling, general and administrative expenses	—			—		—		—		52,898			—			—			52,898
Trade and other accounts receivable, net	—			—		—		—		489,411			247			—			489,658
Depreciation and amortization expense	—			—		—		—		48,400			—			—			48,400
Parts and supplies inventory	—			—		—		—		23,031			—			—			23,031
Income (loss) from operations	—			—		—		—		184,456			(2,382		)	—			182,074
Prepaids and other current assets	—			—		—		—		22,637			179			(4,199		)	18,617
Interest income from restricted assets	—			—		—		—		928			1,503			—			2,431
Current deferred tax assets	—			—		—		—		(3,834		)	3,834			—			—
Interest expense	—			—		—		—		(18,182		)	—			—			(18,182		)
Current assets	—			—		—		—		803,415			55,906			(7,178		)	852,143
Realized gain on investments	—			—		—		—		—			879			—			879
Non-current assets:
Interest and other income	—			—		—		—		748			—			—			748
Property, plant, and equipment, net	—			—		—		—		133,731			—			—			133,731
Loss on early extinguishment of debt	—			—		—		—		(19,091		)	—			—			(19,091		)
Intercompany receivable	—			—		283,557		125,791		—			—			(409,348		)	—
Income before income taxes	—			—		—		—		148,859			—			—			148,859
Intangible assets, net	—			—		—		—		180,374			—			—			180,374
Income tax expense	—			—		—		—		(57,355		)	—			—			(57,355		)
Non-current deferred tax assets	—			—		—		—		4,126			(6,120		)	1,994			—
Income before equity in earnings of unconsolidated subsidiaries	—			—		—		—		91,504			—			—			91,504
Insurance collateral	—			—		—		—		31,664			109,669			(5,270		)	136,063
Equity in earnings of unconsolidated subsidiaries	91,756			91,756		24,087		67,669		252			—			(275,268		)	252
Goodwill	—			—		—		—		426,947			458			—			427,405
Net income	$	91,756		$	91,756	$	24,087	$	67,669	$	91,756		$	—		$	(275,268	)	$	91,756
Other long-term assets	—			—		7,820		3,513		7,503			—			—			18,836
Investment and advances in subsidiaries	847,205			847,205		448,376		398,816		32,981			—			(2,574,583		)	—
Assets	$	847,205		$	847,205	$	739,753	$	528,120	$	1,620,741		$	159,913		$	(2,994,385	)	$	1,748,552
Liabilities and Equity
Current liabilities:
Accounts payable	$	—		$	—	$	—	$	—	$	39,460		$	121		$	—		$	39,581
Accrued liabilities	—			—		747		232		231,297			27,362			—			259,638
Current deferred tax liabilities	—			—		—		—		5,114			—			—			5,114
Current portion of long-term debt	—			—		10,997		4,941		395			—			—			16,333
Current liabilities	—			—		11,744		5,173		276,266			27,483			—			320,666
Long-term debt	—			—		278,587		125,163		1,193			—			—			404,943
Long-term deferred tax liabilities	—			—		—		—		5,971			—			—			5,971
Insurance reserves and other long-term liabilities	—			—		—		—		89,596			90,625			(10,454		)	169,767
Intercompany payable	—			—		—		—		400,524			8,824			(409,348		)	—
Liabilities	—			—		290,331		130,336		773,550			126,932			(419,802		)	901,347
Equity:
Class A common stock	304			—		—		—		—			30			(30		)	304
Class B common stock	1			—		—		—		—			—			—			1
Partnership equity	90,776			394,655		321,581		73,075		393,139			—			(1,182,450		)	90,776
Treasury stock at cost	(1,684		)	—		—		—		—			—			—			(1,684		)
Additional paid-in capital	305,258			—		—		—		—			4,316			(4,316		)	305,258
Retained earnings	450,766			450,766		126,425		324,341		452,268			26,522			(1,380,322		)	450,766
Comprehensive income	1,784			1,784		1,416		368		1,784			2,113			(7,465		)	1,784
Equity	847,205			847,205		449,422		397,784		847,191			32,981			(2,574,583		)	847,205
Liabilities and Equity	$	847,205		$	847,205	$	739,753	$	528,120	$	1,620,741		$	159,913		$	(2,994,385	)	$	1,748,552

Consolidating Statement of Operations

For the nine months ended September 30, 2009

					Issuer		Issuer
					AMR		EmCare		Subsidiary			Subsidiary			Eliminations/
	EMSC		EMS LP		HoldCo, Inc.		HoldCo, Inc.		Guarantors			Non-Guarantor			Adjustments			Total
Net revenue	$	—	$	—	$	—	$	—	$	1,915,369		$	21,256		$	(21,256	)	$	1,915,369
Compensation and benefits	—		—		—		—		1,332,787			—			—			1,332,787
Operating expenses	—		—		—		—		252,355			—			—			252,355
Insurance expense	—		—		—		—		71,693			25,269			(21,256		)	75,706
Selling, general and administrative expenses	—		—		—		—		47,186			—			—			47,186
Depreciation and amortization expense	—		—		—		—		48,658			—			—			48,658
Income (loss) from operations	—		—		—		—		162,690			(4,013		)	—			158,677
Interest income from restricted assets	—		—		—		—		1,485			1,983			—			3,468
Interest expense	—		—		—		—		(30,749		)	—			—			(30,749		)
Realized gain on investments	—		—		—		—		—			2,030			—			2,030
Interest and other income	—		—		—		—		1,442			—			—			1,442
Income before income taxes	—		—		—		—		134,868			—			—			134,868
Income tax expense	—		—		—		—		(53,144		)	—			—			(53,144		)
Income before equity in earnings of unconsolidated subsidiaries	—		—		—		—		81,724			—			—			81,724
Equity in earnings of unconsolidated subsidiaries	81,968		81,968		26,344		55,624		244			—			(245,904		)	244
Net income	$	81,968	$	81,968	$	26,344	$	55,624	$	81,968		$	—		$	(245,904	)	$	81,968

Table of Contents

Consolidating Balance Sheet

As of September 30, 2010

						Issuer		Issuer
						AMR		EmCare		Subsidiary			Subsidiary			Eliminations/
	EMSC			EMS LP		HoldCo, Inc.		HoldCo, Inc.		Guarantors			Non-Guarantor			Adjustments			Total
Assets
Current assets:
Cash and cash equivalents	$	—		$	—	$	—	$	—	$	329,461		$	16,255		$	—		$	345,716
Insurance collateral	—			—		—		—		8,681			32,053			(12,503		)	28,231
Trade and other accounts receivable, net	—			—		—		—		492,234			489			—			492,723
Parts and supplies inventory	—			—		—		—		22,759			—			—			22,759
Prepaids and other current assets	—			—		—		—		24,854			329			(7,932		)	17,251
Current deferred tax assets	—			—		—		—		(3,834		)	3,834			—			—
Current assets	—			—		—		—		874,155			52,960			(20,435		)	906,680
Non-current assets:
Property, plant, and equipment, net	—			—		—		—		126,759			—			—			126,759
Intercompany receivable	—			—		284,948		126,640		—			—			(411,588		)	—
Intangible assets, net	—			—		—		—		138,641			—			—			138,641
Non-current deferred tax assets	—			—		—		—		10,849			(6,120		)	1,994			6,723
Insurance collateral	—			—		—		—		30,977			124,889			(3,917		)	151,949
Goodwill	—			—		—		—		388,048			458			—			388,506
Other long-term assets	—			—		8,273		3,500		6,975			—			—			18,748
Investment and advances in subsidiaries	803,684			803,684		430,943		372,728		35,799			—			(2,446,838		)	—
Assets	$	803,684		$	803,684	$	724,164	$	502,868	$	1,612,203		$	172,187		$	(2,880,784	)	$	1,738,006
Liabilities and Equity
Current liabilities:
Accounts payable	$	—		$	—	$	—	$	—	$	68,172		$	67		$	—		$	68,239
Accrued liabilities	—			—		758		245		236,329			27,272			(1		)	264,603
Current deferred tax liability	—			—		—		—		11,068			—			—			11,068
Current portion of long-term debt	—			—		9,164		4,117		672			—			—			13,953
Current liabilities	—			—		9,922		4,362		316,241			27,339			(1		)	357,863
Long-term debt	—			—		282,253		126,810		1,244			—			—			410,307
Insurance reserves and other long-term liabilities	—			—		—		—		88,284			100,225			(22,357		)	166,152
Intercompany payable	—			—		—		—		402,764			8,824			(411,588		)	—
Liabilities	—			—		292,175		131,172		808,533			136,388			(433,946		)	934,322
Equity:
Class A common stock	303			—		—		—		—			30			(30		)	303
Class B common stock	1			—		—		—		—			—			—			1
Partnership equity	90,776			390,077		319,292		70,786		388,561			—			(1,168,716		)	90,776
Treasury stock at cost	(1,289		)	—		—		—		—			—			—			(1,289		)
Additional paid-in capital	300,286			—		—		—		—			4,316			(4,316		)	300,286
Retained earnings	410,798			410,798		112,346		298,452		412,300			26,522			(1,260,418		)	410,798
Comprehensive income	2,809			2,809		351		2,458		2,809			4,931			(13,358		)	2,809
Equity	803,684			803,684		431,989		371,696		803,670			35,799			(2,446,838		)	803,684
Liabilities and Equity	$	803,684		$	803,684	$	724,164	$	502,868	$	1,612,203		$	172,187		$	(2,880,784	)	$	1,738,006

Table of Contents

Consolidating Balance Sheet

As of December 31, 2009

					Issuer		Issuer
					AMR		EmCare		Subsidiary		Subsidiary			Eliminations/
	EMSC		EMS LP		HoldCo, Inc.		HoldCo, Inc.		Guarantors		Non-Guarantor			Adjustments			Total
Assets
Current assets:
Cash and cash equivalents	$	—	$	—	$	—	$	—	$	317,538	$	15,350		$	—		$	332,888
Insurance collateral	—		—		—		—		10,792		19,450			(5,256		)	24,986
Trade and other accounts receivable, net	—		—		—		—		458,558		530			—			459,088
Parts and supplies inventory	—		—		—		—		22,270		—			—			22,270
Prepaids and other current assets	—		—		—		—		19,650		12			—			19,662
Current deferred tax assets	—		—		—		—		2,489		3,834			—			6,323
Current assets	—		—		—		—		831,297		39,176			(5,256		)	865,217
Non-current assets:
Property, plant, and equipment, net	—		—		—		—		125,855		—			—			125,855
Intercompany receivable	—		—		268,220		185,153		—		—			(453,373		)	—
Intangible assets, net	—		—		—		—		102,654		—			—			102,654
Non-current deferred tax assets	—		—		—		—		19,588		(6,120		)	—			13,468
Insurance collateral	—		—		—		—		56,166		85,165			2,555			143,886
Goodwill	—		—		—		—		381,493		458			—			381,951
Other long-term assets	—		—		4,281		1,898		15,497		—			—			21,676
Investment and advances in subsidiaries	686,087		686,087		394,715		291,358		34,343		—			(2,092,590		)	—
Assets	$	686,087	$	686,087	$	667,216	$	478,409	$	1,566,893	$	118,679		$	(2,548,664	)	$	1,654,707
Liabilities and Equity
Current liabilities:
Accounts payable	$	—	$	—	$	—	$	—	$	70,696	$	63		$	—		$	70,759
Accrued liabilities	—		—		5,117		4,656		231,855		32,077			(1		)	273,704
Current portion of long-term debt	—		—		1,447		650		2,579		—			—			4,676
Current liabilities	—		—		6,564		5,306		305,130		32,140			(1		)	349,139
Long-term debt	—		—		264,891		182,777		1,586		—			—			449,254
Insurance reserves and other long-term liabilities	—		—		—		—		129,555		43,372			(2,700		)	170,227
Intercompany payable	—		—		—		—		444,549		8,824			(453,373		)	—
Liabilities	—		—		271,455		188,083		880,820		84,336			(456,074		)	968,620
Equity:
Class A common stock	295		—		—		—		—		30			(30		)	295
Class B common stock	1		—		—		—		—		—			—			1
Partnership equity	90,776		366,388		307,447		58,941		366,388		—			(1,099,164		)	90,776
Additional paid-in capital	275,316		—		—		—		—		4,316			(4,316		)	275,316
Retained earnings	319,042		319,042		88,261		230,781		319,028		28,080			(985,192		)	319,042
Comprehensive income	657		657		53		604		657		1,917			(3,888		)	657
Equity	686,087		686,087		395,761		290,326		686,073		34,343			(2,092,590		)	686,087
Liabilities and Equity	$	686,087	$	686,087	$	667,216	$	478,409	$	1,566,893	$	118,679		$	(2,548,664	)	$	1,654,707

Table of Contents

Condensed Consolidating Statement of Cash Flows

For the ~~quarter~~three months ended ~~September 30~~March 31, ~~2010~~2011

						Issuer			Issuer
						AMR			EmCare			Subsidiary			Subsidiary
	EMSC			EMS LP		HoldCo Inc.			HoldCo Inc.			Guarantors			Non-guarantors			Total
Cash Flows from Operating Activities
Net cash provided by operating activities	$	—		$	—	$	—		$	—		$	4262,~~954~~424		$	119,~~669~~575		$	5471,~~623~~999
Cash Flows from Investing Activities
Purchase of property, plant and equipment	—			—		—			—			(1615,~~199~~306		)	—			(1615,~~199~~306		)
Proceeds from sale of property, plant and equipment	—			—		—			—			1210			—			1210
Acquisition of businesses, net of cash received	—			—		—			—			(~~183~~32,720		)	—			(~~183~~32,720		)
Net change in insurance collateral	—			—		—			—			618,~~634~~367			(105,~~774~~961		)	(412,~~140~~406		)
Net change in deposits and other assets	—			—		—			—			83474			—			83474
Net cash used in investing activities	—			—		—			—			(929,~~653~~175		)	(105,~~774~~961		)	(2035,~~427~~136		)
Cash Flows from Financing Activities
EMSC issuance of class A common stock	~~221~~551			—		—			—			—			—			~~221~~551
Class A common stock repurchased as treasury stock	(1,~~289~~303		)	—		—			—			—			—			(1,~~289~~303		)
Repayments of capital lease obligations and other debt	—			—		(21,~~157~~273		)	(~~970~~572		)	(~~148~~121		)	—			(31,~~275~~966		)
Borrowings under credit facility	—			—		—			—			—			—			—
Excess tax benefits from stock-based compensation	—			—		—			—			1,169			—			1,169
Debt issue costs	—			—		(151		)	(68		)	—			—			(219		)
Net change in bank overdrafts	—			—		—			—			12,097			—			12,097
Payment of premiums for debt extinguishment	—			—		—			—			—			—			—
Net intercompany borrowings (payments)	752			—		1,273			572			(2,597		)	—			—
Excess tax benefits from stock-based compensation	—			—		—			—			479			—			479
Net cash provided by financing activities	—			—		—			—			10,548			—			10,548
Net change in bank overdrafts	—			—		—			—			2,570			—			2,570
Change in cash and cash equivalents	—			—		—			—			43,797			3,614			47,411
Net intercompany borrowings (payments)	1,068			—		2,308			1,038			(4,414		)	—			—
Cash and cash equivalents, beginning of period	—			—		—			—			265,761			21,600			287,361
Net cash used in financing activities	—			—		—			—			(1,513		)	—			(1,513		)
Cash and cash equivalents, end of period	$	—		$	—	$	—		$	—		$	309,558		$	25,214		$	334,772
Change in cash and cash equivalents	—			—		—			—			31,788			895			32,683
Cash and cash equivalents, beginning of period	—			—		—			—			297,673			15,360			313,033
Cash and cash equivalents, end of period	$	—		$	—	$	—		$	—		$	329,461		$	16,255		$	345,716

Condensed Consolidating Statement of Cash Flows

For the ~~quarter~~three months ended ~~September 30~~March 31, ~~2009~~2010

							~~Issuer~~	Issuer		~~Issuer~~	Issuer
							~~AMR~~	AMR		~~EmCare~~	EmCare		~~Subsidiary~~	Subsidiary		~~Subsidiary~~	Subsidiary
	EMSC			~~EMS LP~~	EMS LP		~~HoldCo Inc.~~	HoldCo Inc.		~~HoldCo Inc.~~	HoldCo Inc.		~~Guarantors~~	Guarantors		~~Non-guarantors~~	Non-guarantors		~~Total~~	Total
Cash Flows from Operating Activities
Net cash provided by (used in) operating activities	$	—	—	$	—$	—	$	—$	—	$	—$	—	$	~~69,172~~$	47,576	$	~~(310~~$	)(2,991	$)	~~68,862~~$	44,585
Cash Flows from Investing Activities
Purchase of property, plant and equipment	—			—	—		—	—		—	—		~~(13,576~~	(6,516	)	—)	—		~~(13,576~~	(6,516	)	)
Proceeds from sale of property, plant and equipment	—			—	—		—	—		—	—		41	42		—	—		41	42
Acquisition of businesses, net of cash received	—			—	—		—	—		—	—		~~(1,241~~	(3,300	)	—)	—		~~(1,241~~	(3,300	)	)
Net change in insurance collateral	—			—	—		—	—		—	—		~~(9,241~~	(635	)	~~15,243~~)	3,001		~~6,002~~	2,366
Net change in deposits and other assets	—			—	—		—	—		—	—		~~(166~~	290	)	—	—		~~(166~~	290	)
Net cash (used in) provided by investing activities	—			—	—		—	—		—	—		~~(24,183~~	(10,119	)	~~15,243~~)	3,001		~~(8,940~~	(7,118	)	)
Cash Flows from Financing Activities
EMSC issuance of class A common stock	24,~~437~~402			—	—		—	—		—	—		—	—		—	—		~~2,437~~	4,402
Repayments of capital lease obligations and other debt	—			—	—		—	—		—	—		~~(1,214~~	(1,184	)	—)	—		~~(1,214~~	(1,184	)	)
Increase in bank overdrafts	—			—			—			—			2,821			—			2,821
Excess tax benefits from share-based compensation	—				—			—			—			10,581			—			10,581
Net intercompany borrowings (payments)	(2,437		)	—			—			—			2,437			—			—
Increase in bank overdrafts	—				—			—			—			(3,099		)	—			(3,099		)
Net cash provided by financing activities	—			—			—			—			4,044			—			4,044
Net intercompany borrowings (payments)	(4,402			)	—			—			—			4,402			—			—
Change in cash and cash equivalents	—			—			—			—			49,033			14,933			63,966
Net cash provided by financing activities	—				—			—			—			10,700			—			10,700
Cash and cash equivalents, beginning of period	—			—			—			—			266,772			367			267,139
Change in cash and cash equivalents	—				—			—			—			48,157			10			48,167
Cash and cash equivalents, end of period	$	—		$	—		$	—		$	—		$	315,805		$	15,300		$	331,105
Cash and cash equivalents, beginning of period	—				—			—			—			317,538			15,350			332,888
Cash and cash equivalents, end of period	$		—		$	—		$	—		$	—		$	365,695		$	15,360		$	381,055

Table of Contents

Condensed Consolidating Statement of Cash Flows

For the nine months ended September 30, 2010

						Issuer			Issuer
						AMR			EmCare			Subsidiary			Subsidiary
	EMSC			EMS LP		HoldCo Inc.			HoldCo Inc.			Guarantors			Non-guarantors			Total
Cash Flows from Operating Activities
Net cash provided by operating activities	$	—		$	—	$	—		$	—		$	99,852		$	39,513		$	139,365
Cash Flows from Investing Activities
Purchase of property, plant and equipment	—			—		—			—			(31,367		)	—			(31,367		)
Proceeds from sale of property, plant and equipment	—			—		—			—			120			—			120
Acquisition of businesses, net of cash received	—			—		—			—			(51,158		)	—			(51,158		)
Net change in insurance collateral	—			—		—			—			29,207			(38,608		)	(9,401		)
Net change in deposits and other assets	—			—		—			—			11,021			—			11,021
Net cash used in investing activities	—			—		—			—			(42,177		)	(38,608		)	(80,785		)
Cash Flows from Financing Activities
EMSC issuance of class A common stock	6,414			—		—			—			—			—			6,414
Class A common stock repurchased as treasury stock	(1,289		)	—		—			—			—			—			(1,289		)
Repayments of capital lease obligations and other debt	—			—		(312,495		)	(140,397		)	(3,010		)	—			(455,902		)
Borrowings under credit facility	—			—		293,250			131,750			—			—			425,000
Debt issue costs	—			—		(8,258		)	(3,710		)	—			—			(11,968		)
Payment of premiums for debt extinguishment	—			—		(10,014		)	(4,499		)	—			—			(14,513		)
Excess tax benefits from stock-based compensation	—			—		—			—			13,977			—			13,977
Net change in bank overdrafts	—			—		—			—			(7,471		)	—			(7,471		)
Net intercompany borrowings (payments)	(5,125		)	—		37,517			16,856			(49,248		)	—			—
Net cash used in financing activities	—			—		—			—			(45,752		)	—			(45,752		)
Change in cash and cash equivalents	—			—		—			—			11,923			905			12,828
Cash and cash equivalents, beginning of period	—			—		—			—			317,538			15,350			332,888
Cash and cash equivalents, end of period	$	—		$	—	$	—		$	—		$	329,461		$	16,255		$	345,716

Condensed Consolidating Statement of Cash Flows

For the nine months ended September 30, 2009

						Issuer		Issuer
						AMR		EmCare		Subsidiary			Subsidiary
	EMSC			EMS LP		HoldCo Inc.		HoldCo Inc.		Guarantors			Non-guarantors			Total
Cash Flows from Operating Activities
Net cash provided by (used in) operating activities	$	—		$	—	$	—	$	—	$	213,794		$	(3,993	)	$	209,801
Cash Flows from Investing Activities
Purchase of property, plant and equipment	—			—		—		—		(33,661		)	—			(33,661		)
Proceeds from sale of property, plant and equipment	—			—		—		—		101			—			101
Acquisition of businesses, net of cash received	—			—		—		—		(1,374		)	—			(1,374		)
Net change in insurance collateral	—			—		—		—		(9,503		)	13,572			4,069
Net change in deposits and other assets	—			—		—		—		(809		)	—			(809		)
Net cash (used in) provided by investing activities	—			—		—		—		(45,246		)	13,572			(31,674		)
Cash Flows from Financing Activities
EMSC issuance of class A common stock	7,160			—		—		—		—			—			7,160
Repayments of capital lease obligations and other debt	—			—		—		—		(3,826		)	—			(3,826		)
Increase in bank overdrafts	—			—		—		—		3,471			—			3,471
Net intercompany borrowings (payments)	(7,160		)	—		—		—		7,160			—			—
Net cash provided by financing activities	—			—		—		—		6,805			—			6,805
Change in cash and cash equivalents	—			—		—		—		175,353			9,579			184,932
Cash and cash equivalents, beginning of period	—			—		—		—		140,452			5,721			146,173
Cash and cash equivalents, end of period	$	—		$	—	$	—	$	—	$	315,805		$	15,300		$	331,105

11. Subsequent Events

The Company’s management has evaluated events subsequent to ~~September~~March 3031, ~~2010~~2011 through the ~~issue~~issuance date of this report~~. There~~ ~~has been~~to noidentify ~~material~~any ~~event~~necessary ~~noted~~changes into ~~this~~the ~~period~~consolidated ~~which~~financial ~~would~~statements ~~either~~or ~~impact~~related ~~the results~~disclosures. Below ~~reflected~~is ina ~~this~~description ~~report~~of orevents ~~the~~for ~~Company’s~~which ~~results~~disclosure ~~going~~was ~~forward~~deemed necessary.

1916

Table of Contents

Completion of the Merger contemplated by the Merger Agreement (see Note 1 - General; Merger Agreement) is subject to customary closing conditions, including, among others, (a) approval of the adoption of the Merger Agreement by a majority of the voting power of the outstanding capital stock of the Company, (b) expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended and (c) the absence of any material adverse change in the Company. The holders of the LP exchangeable units, who hold approximately 81% of the voting power of the capital stock of EMSC, have agreed to vote to approve the adoption of the Merger Agreement. A special meeting of the stockholders to vote on the approval of the adoption of the Merger Agreement has been called for on May 20, 2011.

On April 1, 2011, the Company acquired all the capital stock of BestPractices, Inc., an emergency department staffing and management company based in Virginia.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements and Factors That May Affect Results

Certain statements and information herein may be deemed to be “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Any forward-looking statements herein are made as of the date this Quarterly Report on Form 10-Q is filed with the Securities and Exchange Commission, and EMSC undertakes no duty to update or revise any such statements. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in EMSC’s filings with the SEC from time to time, including in the section entitled “Risk Factors” in EMSC’s most recent Annual Report on Form 10-K and in subsequent Quarterly Reports on Form 10-Q. Among the factors that could cause future results to differ materially from those provided in this Quarterly Report on Form 10-Q are: the impact on our revenue of changes in transport volume, mix of insured and uninsured patients, and third party reimbursement rates and methods; the adequacy of our insurance coverage and insurance reserves; potential penalties or changes to our operations if we fail to comply with extensive and complex government regulation of our industry, both as it exists now and as it may change in the future; the impact of changes in the healthcare industry; our ability to recruit and retain qualified physicians and other healthcare professionals, and enforce our non-compete agreements with our physicians; ~~our ability to generate cash flow to service our debt obligations;~~ the ~~cost of capital expenditures to maintain and upgrade our vehicle fleet and medical equipment; the~~ loss of one or more members of our senior management team; the outcome of government investigations of certain of our business practices; our ability to ~~successfully~~generate ~~restructure~~cash flow to service our ~~operations~~debt obligations and fund the cost of capital expenditures to ~~comply~~maintain ~~with~~and ~~future changes~~upgrade inour ~~government~~vehicle ~~regulation~~fleet and medical equipment; and the loss of existing contracts and the accuracy of our assessment of costs under new contracts; the high level of competition in our industry; our ability to maintain or implement complex information systems; our ability to implement our business strategy; our ability to successfully integrate strategic acquisitions; and our ability to comply with the terms of our settlement agreements with the government.

All references to “we”, “our”, “us” or “EMSC” refer to Emergency Medical Services Corporation and its subsidiaries, including Emergency Medical Services L.P., or EMS LP. Our business is conducted primarily through two operating subsidiaries, American Medical Response, Inc., or AMR, and EmCare Holdings Inc., or EmCare.

This Report should be read in conjunction with EMSC’s consolidated financial statements and notes thereto included in our Annual Report on Form 10-K filed with the SEC on February 1918, ~~2010~~ 2011.

Company Overview

We are a leading provider of medical transportation services and facility-based physician services in the United States. We operate our business and market our services under the AMR and EmCare brands. AMR, over its more than 50 years of operating history, is a leading provider of ground and fixed-wing ambulance services in the United States based on net revenue and number of transports. EmCare, over its more than 35 years of operating history, is a leading provider of physician services in the United States based on number of contracts with hospitals and affiliated physician groups. Through EmCare, we provide facility-based physician services for emergency departments and hospitalist/inpatient, anesthesiology, radiology, and teleradiology programs.

Key Factors and Measures We Use to Evaluate Our Business

The key factors and measures we use to evaluate our business focus on the number of patients we treat and transport and the costs we incur to provide the necessary care and transportation for each of our patients.

We evaluate our revenue net of provisions for contractual payor discounts and provisions for uncompensated care. Medicaid, Medicare and certain other payors receive discounts from our standard charges, which we refer to as contractual discounts. In addition, individuals we treat and transport may be personally responsible for a deductible or co-pay under their third party payor coverage, and most of our contracts require us to treat and transport patients who have no insurance or other third party payor coverage. Due to the uncertainty regarding ~~collectibility~~ collectability of charges associated with services we provide to these patients, which we refer to as uncompensated care, our net revenue recognition is based on expected cash collections. Our net revenue represents gross billings after provisions for contractual discounts and estimated uncompensated care. Provisions for contractual discounts and uncompensated care have increased historically primarily as a result of increases in gross billing rates without corresponding increases in payor reimbursement.

The table below summarizes our approximate payor mix as a percentage of both net revenue and total transports and patient ~~visits~~encounters for the ~~three~~quarters ~~and nine months~~ ended ~~September~~March 3031, ~~2010~~ 2011 and ~~2009~~2010. In determining the net revenue payor mix, we use cash

2018

Table of Contents

collections in the period as an approximation of net revenue recorded.

	Percentage of Cash Collections (Net Revenue)				Percentage of Total Volume				~~Percentage of Total Volume~~
	Quarter ended September 30,				Nine months ended September 30,				Quarter ended September 30,				Nine months ended September 30,
	Q1 2011		Q1 2010		Q1 2011		Q1 2010
	2010		2009		2010		2009		2010		2009		2010		2009
Medicare	22.3	%	22.1	%	26.4	%	25.0	%
Medicare	22.2	%	22.4	%	22.0	%	23.2	%	25.5	%	23.7	%	25.1	%	24.6	%
Medicaid	6.0	%	5.0	%	13.2	%	12.2	%
Medicaid	5.8	%	4.9	%	5.4	%	4.7	%	13.3	%	11.4	%	12.7	%	11.2	%
Commercial insurance and managed care	48.4	%	49.6	%	42.4	%	42.8	%
Commercial insurance and managed care	47.5	%	50.2	%	49.0	%	50.5	%	41.0	%	42.9	%	42.4	%	42.7	%
Self-pay	4.6	%	4.2	%	18.0	%	20.0	%
Self-pay	4.4	%	3.8	%	4.2	%	3.9	%	20.2	%	22.0	%	19.8	%	21.5	%
Fees and subsidies	18.7	%	19.1	%	—		—
Subsidies & fees	20.1	%	18.7	%	19.4	%	17.7	%	—		—		—		—
Total	100.0	%	100.0	%	100.0	%	100.0	%
Total	100.0	%	100.0	%	100.0	%	100.0	%	100.0	%	100.0	%	100.0	%	100.0	%

Our ~~2010~~2011 volume mix has been positively impacted compared to our ~~2009~~2010 volume mix primarily ~~due~~by to the ~~recent~~ continued expansion of our anesthesia business, which has a lower percentage of self-pay ~~mix~~ ~~when~~volume ~~compared~~than to our emergency department, radiology and inpatient services ~~businesses,~~ ~~and due to a decreased percentage of self-pay patients treated in 2010~~businesses. ~~Our payor mix was negatively impacted during the 2009 periods presented due to an increased level of self-pay patients treated in response to the H1N1 virus, which did not recur in 2010.~~

In addition to continually monitoring our payor mix, we also analyze certain measures in each of our business segments.

AMR

Approximately 8687% of AMR’s net revenue for the ~~nine~~three months ended ~~September~~March 3031, ~~2010~~2011 was transport revenue derived from the treatment and transportation of patients, including fixed wing medical transportation services, based on billings to third party payors, healthcare facilities and patients. The balance of AMR’s net revenue is derived from direct billings to communities, and government agencies ~~and other contracted customers~~ for the provision of training, dispatch center and other services. AMR’s measures for net revenue include transports, segregated into ambulance and wheelchair transports and that we weight in certain analyses, and net revenue per transport.

The change from period to period in the number of transports and net revenue per transport is influenced by the mix of emergency versus non-emergency transports, changes in transports in existing markets from both new and existing facilities we serve for non-emergency transports, the effects of general community conditions for emergency transports and the impact of newly acquired businesses and markets AMR has exited.

The costs we incur in our AMR business segment consist primarily of compensation and benefits for ~~medical~~ ambulance crews and support personnel, direct and indirect operating costs to provide transportation services, and costs related to accident and insurance claims. AMR’s key cost measures include unit hours and cost per unit hour (to measure compensation-related costs and the efficiency of our ambulance deployment), operating costs per transport, and accident and insurance claims.

We have focused our risk mitigation efforts on employee training for proper patient handling techniques, development of clinical and medical equipment protocols, driving safety, implementation of technology to reduce auto incidents and other risk mitigation processes which we believe have resulted in a reduction in the frequency, severity and development of claims.

Our AMR business segment requires various investments in long-term assets and depreciation expense relates primarily to charges for usage of these assets, including vehicles, computer hardware and software, equipment, and other technologies. Amortization expense relates primarily to intangibles recorded for customer relationships.

EmCare

Of EmCare’s net revenue for the ~~nine~~three months ended ~~September~~March 3031, ~~2010~~2011, approximately 7873% was derived from our hospital contracts for emergency department staffing, ~~and approximately 22~~16% ~~was~~from ~~derived~~contracts ~~from~~related ~~hospitalist,~~to anesthesiology services, ~~radiology~~5% from our hospitalist/inpatient services, 4% from our services provided to radiology/teleradiology services, and 2% from other hospital management services. Approximately 7778% of EmCare’s net revenue was generated from billings to third party payors and patients for patient encounters and approximately 2322% was generated from billings to hospitals and affiliated physician groups for professional services. EmCare’s key net revenue measures are patient encounters, segregated into emergency department visits, radiology reads, and anesthesiology and hospitalist encounters and that we weight in certain analyses, net revenue per patient encounter, and number of contracts.

The change from period to period in the number of patient encounters under our “same store” contracts is influenced by general community conditions as well as hospital-specific elements, many of which are beyond our direct control.

21The costs incurred in our EmCare business segment consist primarily of compensation and benefits for physicians and

Table of Contents

~~general community conditions~~other asprofessional ~~well~~providers, asprofessional ~~hospital-specific~~liability ~~elements~~costs, ~~many~~and ofcontract ~~which~~and ~~are~~other ~~beyond~~support ~~our direct~~costs. ~~control~~EmCare’s key cost measures include provider compensation per patient encounter and professional liability costs.

The costs incurred in our EmCare business segment consist primarily of compensation and benefits for physicians and other professional providers, professional liability costs, and contract and other support costs. EmCare’s key cost measures include provider compensation per patient encounter and professional liability costs.

We have developed extensive professional liability risk mitigation processes, including risk assessments on medical professionals and hospitals, extensive incident reporting and tracking processes, clinical fail-safe programs, training and education and other risk mitigation programs which we believe have resulted in a reduction in the frequency, severity and development of claims.

Our EmCare business segment is less capital intensive than AMR, and EmCare’s depreciation expense relates primarily to charges for usage of computer hardware and software, and other technologies. Amortization expense relates primarily to intangibles recorded for customer relationships.

Factors Affecting Operating Results

Changes in Net New Contracts

Our operating results are affected directly by the number of net new contracts and related volumes we have in a period, reflecting the effects of both new contracts and contract expirations. We regularly bid for new contracts, frequently in a formal competitive bidding process that often requires written responses to a Request for Proposal, or RFP, and, in any fiscal period, certain of our contracts will expire. We may elect not to seek extension or renewal of a contract, or may reduce certain services, if we determine that we cannot continue to provide such services on favorable terms. With respect to expiring contracts we would like to renew, we may be required to seek renewal through an RFP, and we may not be successful in retaining any such contracts, or retaining them on terms that are as favorable as present terms. For the year ended December 31, 2010, AMR and EmCare’s contract retention rates were 99% and 88%, respectively.

Inflation

Certain of our expenses, such as wages and benefits, insurance, fuel and equipment repair and maintenance costs, are subject to normal inflationary pressures. Fuel expense represented 10.67% and 9.76% of AMR’s operating expenses for the three months ~~ended~~ ~~September 30, 2010 and 2009, respectively, and 10.1% and 8.9% for the nine months~~ ended ~~September~~March 3031, ~~2010~~2011 and ~~2009~~2010, respectively. Although we have generally been able to offset inflationary ~~and other~~ cost increases through increased operating efficiencies and successful negotiation of fees and subsidies, we can provide no assurance that we will be able to offset any future inflationary cost increases through similar efficiencies and fee changes.

Critical Accounting Policies

Revenue Recognition

Revenue is recognized at the time of service and is recorded net of provisions for contractual discounts and estimated uncompensated care. We estimate our provision for contractual discounts and uncompensated care based on payor reimbursement schedules, historical collections and write-off experience and other economic data. As a result of the estimates used in recording the provisions, and the nature of healthcare collections, which may involve lengthy delays, there is a reasonable possibility that recorded estimates will change materially in the short-term.

The changes in the provisions for contractual discounts and uncompensated care are primarily a result of changes in our gross fee-for-service rate schedules and gross accounts receivable balances. These gross fee schedules, including any changes to existing fee schedules, generally are negotiated with various contracting entities, including municipalities and facilities. Fee schedule increases are billed for all revenue sources and to all payors under that specific contract; however, reimbursement in the case of certain state and federal payors, including Medicare and Medicaid, will not change as a result of the change in gross fee schedules. In certain cases, this results in a higher level of contractual and uncompensated care provisions and allowances, requiring a higher percentage of contractual discount and uncompensated care provisions compared to gross charges.

In addition, management analyzes the ultimate collectability of revenue and accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected. Adjustments related to this analysis are recorded as a reduction or increase to net revenue each month, and were less than 1% of net revenue for the ~~three~~each ~~and~~of ~~nine~~three month periods ~~ended~~ending ~~September~~March 3031, ~~2010~~ 2011 and ~~2009~~2010.

Table of Contents

Results of Operations

~~Three~~Quarter ~~and Nine Months~~ Ended ~~September~~March 3031, ~~2010~~2011 Compared to ~~Three~~the ~~and~~Quarter ~~Nine Months~~ Ended ~~September~~March 3031, ~~2009~~2010

The following tables present a comparison of financial data from our unaudited consolidated statements of operations for ~~the three and nine months ended September 30, 2010 and for the three and nine months ended September 30, 2009 for EMSC and our two operating segments.~~

Table of Contents

the three months ended March 31, 2011 and 2010 for EMSC and our two operating segments.

Non-GAAP Measures

Adjusted EBITDA. Adjusted EBITDA is defined as net income before equity in earnings of unconsolidated subsidiary, income tax expense, ~~loss on early debt extinguishment,~~ interest and other (expense) income, realized (loss) gain on investments, interest expense and depreciation and amortization expense. Adjusted EBITDA is commonly used by management and investors as a performance measure and liquidity indicator. Adjusted EBITDA is not considered a measure of financial performance under U.S. generally accepted accounting principles, or GAAP, and the items excluded from Adjusted EBITDA are significant components in understanding and assessing our financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to such GAAP measures as net income, cash flows provided by or used in operating, investing or financing activities or other financial statement data presented in our financial statements as an indicator of financial performance or liquidity. Since Adjusted EBITDA is not a measure determined in accordance with GAAP and is susceptible to varying calculations, Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. The tables set forth a reconciliation of Adjusted EBITDA to net income and cash flows provided by operating activities.

Unaudited Consolidated Results of Operations and as a Percentage of Net Revenue

(dollars in thousands)

EMSC

	Quarter ended September 30, 2010					Quarter ended September 30, 2009					Nine months ended September 30, 2010					Nine months ended September 30, 2009
	Quarter ended March 31, 2011					Quarter ended March 31, 2010
				% of net revenue					% of net revenue					~~% of net revenue~~					~~% of net revenue~~
Net revenue	$	~~737~~760,~~180~~835		100.0	%	$	~~665~~679,~~056~~354		100.0	%	$	~~2,125,338~~		~~100.0~~	%	$	~~1,915,369~~		~~100.0~~	%
Compensation and benefits	~~523~~537,~~263~~077			7170.06		~~467~~480,~~625~~317			70.37		~~1,500,023~~			~~70.6~~		~~1,332,787~~			~~69.6~~
Operating expenses	9196,~~023~~963			12.37		8586,~~510~~529			12.97		~~268,138~~			~~12.6~~		~~252,355~~			~~13.2~~
Insurance expense	2526,~~793~~539			3.5		2422,~~845~~070			3.72		~~73,805~~			~~3.5~~		~~75,706~~			~~4.0~~
Selling, general and administrative expenses	17,~~742~~835			2.43		1516,~~871~~858			2.45		~~52,898~~			~~2.5~~		~~47,186~~			~~2.5~~
Interest income from restricted assets	(~~717~~396		)	(0.1	)	(~~1,082~~855		)	(0.21	)	~~(2,431~~		)	~~(0.1~~	)	~~(3,468~~		)	~~(0.2~~	)
Adjusted EBITDA	$82,817	~~80,076~~		10.9	%	$74,435	~~72,287~~		1011.90	%	$	~~232,905~~		~~11.0~~	%	$	~~210,803~~		~~11.0~~	%
Depreciation and amortization expense	(1617,~~528~~525		)	(2.23	)	(1516,~~733~~180		)	(2.4	)	~~(48,400~~		)	~~(2.3~~	)	~~(48,658~~		)	~~(2.5~~	)
Interest expense	(4,~~856~~817		)	(0.76	)	(108,~~280~~266		)	(1.52	)	~~(18,182~~		)	~~(0.9~~	)	~~(30,749~~		)	~~(1.6~~	)
Realized gain on investments	730			0.1		544			0.1		879			0.0		2,030			0.1
Realized (loss) gain on investments	(4		)	(0.0	)	92			0.0
Interest and other income	277			0.0		502			0.1		748			0.0		1,442			0.1
Interest and other (expense) income	(1,746		)	(0.2	)	265			0.0
Loss on early debt extinguishment	—			—		—			—		(19,091		)	(0.9	)	—			—
Income tax expense	(22,652		)	(3.0	)	(19,410		)	(2.9	)
Income tax expense	(22,990		)	(3.1	)	(18,533		)	(2.8	)	(57,355		)	(2.7	)	(53,144		)	(2.8	)
Equity in earnings of unconsolidated subsidiary	91			0.0		94			0.0
Equity in earnings of unconsolidated subsidiary	53			0.0		91			0.0		252			0.0		244			0.0
Net income	$	36,164		4.8	%	$	31,030		4.6	%
Net income	$	36,762		5.0	%	$	28,878		4.3	%	$	91,756		4.3	%	$	81,968		4.3	%

Table of Contents

Unaudited Reconciliation of Adjusted EBITDA to Cash Flows Provided by Operating Activities

(dollars in thousands)

	Quarter ended September 30,						Nine months ended September 30,
	Quarter ended March 31,
	2010			2009			2010			2009
	2011			2010
Adjusted EBITDA	$	8082,~~076~~817		$	7274,~~287~~435		$	~~232,905~~		$	~~210,803~~
Interest paid	(4,195		)	(9,773		)	(16,385		)	(29,424		)
Interest expense (less deferred loan fee amortization)	(4,017		)	(7,759		)
Change in accounts receivable	(10,~~882~~762		)	72,~~574~~191			~~(30,441~~		)	~~8,448~~
Change in other operating assets/liabilities	1126,~~164~~769			(23,~~956~~934		)	~~18,192~~			~~16,000~~
Equity based compensation	21,~~042~~962			1,~~121~~104			~~4,587~~			~~2,875~~
Excess tax benefits from stock-based compensation	(~~479~~1,169		)	—(10,581		)	~~(13,977~~		)	—
Income tax expense, net of change in deferred taxes	(2422,~~092~~307		)	(~~472~~19,543		)	~~(57,617~~		)	~~(3,155~~		)
Other	~~989~~(1,294		)	~~1,081~~804			~~2,101~~			~~4,254~~
Cash flows provided by operating activities	$	5471,~~623~~999		$	6844,~~862~~585		$	~~139,365~~		$	~~209,801~~

Table of Contents

Unaudited Segment Results of Operations and as a Percentage of Net Revenue

(dollars in thousands)

AMR

	Quarter ended September 30, 2010					Quarter ended September 30, 2009					Nine months ended September 30, 2010					Nine months ended September 30, 2009
	Quarter ended March 31, 2011					Quarter ended March 31, 2010
				% of net revenue					% of net revenue					% of net revenue					% of net revenue
				% of net Revenue					% of net revenue
Net revenue	$	~~352~~364,~~226~~208		100.0	%	$	~~338~~336,~~768~~962		100.0	%	$	~~1,033,347~~		~~100.0~~	%	$	~~1,010,718~~		~~100.0~~	%
Compensation and benefits	~~221~~222,~~426~~038			6261.90		~~211~~208,~~921~~351			6261.68		~~641,079~~			~~62.0~~		~~628,015~~			~~62.1~~
Operating expenses	7984,~~749~~290			2223.61		75,~~677~~639			22.34		~~233,827~~			~~22.6~~		~~222,296~~			~~22.0~~
Insurance expense	911,~~379~~882			23.73		1011,~~417~~185			3.13		~~33,339~~			~~3.2~~		~~35,433~~			~~3.5~~
Selling, general and administrative expenses	10,~~463~~640			32.09		9,~~410~~729			2.89		~~30,419~~			~~2.9~~		~~28,308~~			~~2.8~~
Interest income from restricted assets	(~~240~~231		)	(0.1	)	(~~495~~344		)	(0.1	)	~~(928~~		)	~~(0.1~~	)	~~(1,485~~		)	~~(0.1~~	)
Adjusted EBITDA	$35,589	~~31,449~~		8.9.8	%	$32,402	~~31,838~~		9.46	%	$	~~95,611~~		~~9.3~~	%	$	~~98,151~~		~~9.7~~	%
Reconciliation of Adjusted EBITDA to income from operations
Adjusted EBITDA	3135,~~449~~589			8.9.8		3132,~~838~~402			9.46		~~95,611~~			~~9.3~~		~~98,151~~			~~9.7~~
Depreciation and amortization expense	(11,~~325~~571		)	(3.2	)	(1211,~~199~~234		)	(3.63	)	~~(33,629~~		)	~~(3.3~~	)	~~(37,147~~		)	~~(3.7~~	)
Interest income from restricted assets	(~~240~~231		)	(0.1	)	(~~495~~344		)	(0.1	)	~~(928~~		)	~~(0.1~~	)	~~(1,485~~		)	~~(0.1~~	)
Income from operations	$	1923,~~884~~787		5.6.5	%	$	1920,~~144~~824		56.72	%	$	~~61,054~~		~~5.9~~	%	$	~~59,519~~		~~5.9~~	%

EmCare

	Quarter ended September 30, 2010					Quarter ended September 30, 2009					Nine months ended September 30, 2010					Nine months ended September 30, 2009
	Quarter ended March 31, 2011					Quarter ended March 31, 2010
				% of net revenue					% of net revenue					~~% of net revenue~~					~~% of net revenue~~
Net revenue	$	~~384~~396,~~954~~627		100.0	%	$	~~326~~342,~~288~~392		100.0	%	$	~~1,091,991~~		~~100.0~~	%	$	~~904,651~~		~~100.0~~	%
Compensation and benefits	~~301~~315,~~837~~039			7879.4		~~255~~271,~~704~~966			7879.4		~~858,944~~			~~78.7~~		~~704,772~~			~~77.9~~
Operating expenses	1112,~~274~~673			23.92		910,~~833~~890			3.02		~~34,311~~			~~3.1~~		~~30,059~~			~~3.3~~
Insurance expense	1614,~~414~~657			4.3.7		1410,~~428~~885			43.42		~~40,466~~			~~3.7~~		~~40,273~~			~~4.5~~
Selling, general and administrative expenses	7,~~279~~195			1.98		67,~~461~~129			2.01		~~22,479~~			~~2.1~~		~~18,878~~			~~2.1~~
Interest income from restricted assets	(~~477~~165		)	(0.10	)	(~~587~~511		)	(0.21	)	~~(1,503~~		)	~~(0.1~~	)	~~(1,983~~		)	~~(0.2~~	)
Adjusted EBITDA	$47,228	~~48,627~~		1211.69	%	$42,033	~~40,449~~		12.43	%	$	~~137,294~~		~~12.6~~	%	$	~~112,652~~		~~12.5~~	%
Reconciliation of Adjusted EBITDA to income from operations
Adjusted EBITDA	4847,~~627~~228			1211.69		4042,~~449~~033			12.43		~~137,294~~			~~12.6~~		~~112,652~~			~~12.5~~
Depreciation and amortization expense	(5,203		)	(1.4	)	(3,534		)	(1.1	)	(14,771		)	(1.4	)	(11,511		)	(1.3	)
Depreciation and amortization expenses	(5,954		)	(1.5	)	(4,946		)	(1.4	)
Interest income from restricted assets	(~~477~~165		)	(0.10	)	(~~587~~511		)	(0.21	)	~~(1,503~~		)	~~(0.1~~	)	~~(1,983~~		)	~~(0.2~~	)
Income from operations	$	4241,~~947~~109		1110.24	%	$	36,~~328~~576		1110.17	%	$	~~121,020~~		~~11.1~~	%	$	~~99,158~~		~~11.0~~	%

24Quarter ended March 31, 2011 compared to the quarter ended March 31, 2010

Table of Contents

Quarter ended September 30, 2010 compared to the quarter ended September 30, 2009

Consolidated

Our results for the three months ended ~~September~~March 3031, ~~2010~~2011 reflect an increase in net revenue of $7281.15 million and an increase in net income of $75.91 million compared to the three months ended ~~September~~March 3031, ~~2009~~2010. The increase in net income ~~was~~ is attributable primarily to growth in income from operations and a decrease in interest expense, partially offset by an increase in income tax expense. During the three months ended March 31, 2011, we also recorded $2.0 million for fees associated with the proposed Merger transaction with affiliates of Clayton, Dubilier & Rice, LLC which are included in interest and other (expense) income (see Note 1 to the accompanying unaudited consolidated financial statements). Basic and diluted earnings per share were $0.8382 and $0.8280, respectively, for the three months ended ~~September~~March 3031, ~~2010~~2011. Basic and diluted earnings per share were $0.6771 and $0.6670, respectively, for the same period in ~~2009~~2010.

Net revenue. For the three months ended ~~September~~March 3031, ~~2010~~2011, we generated net revenue of $~~737~~760.2 8 million compared to net revenue of $~~665~~679.~~1million~~4 million for the three months ended ~~September~~March 3031, ~~2009~~ 2010, representing an increase of 1012.80%. The increase is attributable primarily to increases in ~~revenues~~rates and volumes on existing contracts ~~and~~combined with increased volume from net new contracts and acquisitions.

Adjusted EBITDA. Adjusted EBITDA was $8082.18 million, or 10.9% of net revenue, for the three months ended ~~September~~ March 3031, ~~2010~~2011 compared to $7274.34 million, or 1011.90% of net revenue, for the three months ended ~~September~~March 3031, ~~2009~~2010.

Interest expense. Interest expense for the three months ended ~~September~~ March 3031, ~~2010~~2011 was $4.98 million compared to $108.3 million for the three months ended September 30, 2009. The decrease was due to entering into our new credit facility in April 2010 and the redemption of our senior subordinated notes which resulted in a decrease to our effective interest rate compared to our previous debt structure.

Income tax expense. Income tax expense increased by $4.5 million for the three months ended September 30, 2010 compared to the same period in 2009. Our effective tax rate for the three months ended September 30, 2010 was 38.5%, and 39.2% for the same period in 2009.22

AMR

Net revenue. Net revenue for the three months ended September 30, 2010 was $352.2 million, an increase of $13.5 million, or 4.0%, from $338.8 million for the same period in 2009. The increase in net revenue was due primarily to an increase in net revenue per weighted transport of 2.3%, or $7.6 million, and an increase of 1.7%, or $5.9 million, in weighted transport volume. The increase in net revenue per weighted transport was primarily due to growth in our managed transportation business combined with other non-transport related revenue increases. Weighted transports increased 12,500 from the same period last year. This change was due to an increase in weighted transport volume in existing markets of 0.4%, or 3,000 weighted transports, and an increase of 10,600 weighted transports from our entry into new markets, which increases were offset partially by a decrease of 1,100 weighted transports from the exit of certain markets.

Compensation and benefits. Compensation and benefit costs for the three months ended September 30, 2010 were $221.4 million, or 62.9% of net revenue, compared to $211.9 million, or 62.6% of net revenue, for the same period in 2009. Ambulance crew wages per ambulance unit hour increased by approximately 5.0%, or $5.9 million attributable primarily to wage rate increases. While weighted transport volume increased from the same period last year, ambulance unit hours decreased by 0.3%, or $0.4 million, due primarily to the increased efficiency in our ambulance unit hour deployment. During the three months ended September 30, 2010, we incurred $2.5 million in increased medical claim charges associated with several large claims in our self-insured health plans compared to the same period in 2009. We have historically not seen the number and types of large claims we incurred in the third quarter of 2010.

Operating expenses. Operating expenses for the three months ended September 30, 2010 were $79.7 million, or 22.6% of net revenue, compared to $75.7 million, or 22.3% of net revenue, for the three months ended September 30, 2009. The change is due primarily to increased fuel costs of $1.0 million, increased costs associated with growth in our managed transportation business of $0.9 million, and increased costs associated with our entry into new markets of $0.8 million.

Insurance expense. Insurance expense for the three months ended September 30, 2010 was $9.4 million, or 2.7% of net revenue, compared to $10.4 million, or 3.1% of net revenue, for the same period in 2009. We recorded a reduction of prior year insurance provisions of $3.0 million during the three months ended September 30, 2010 and $2.1 million during the three months ended September 30, 2009.

Selling, general and administrative. Selling, general and administrative expense for the three months ended September 30, 2010 was $10.5 million, or 3.0% of net revenue, compared to $9.4 million, or 2.8% of net revenue, for the three months ended September 30, 2009.

Table of Contents

~~Depreciation and amortization. Depreciation and amortization expense for~~ the three months ended ~~September~~March 3031, 2010. The decrease was ~~$11.3~~due ~~million,~~to orthe ~~3.2%~~reduction of ~~net revenue,~~our ~~compared~~effective tointerest ~~$12.2~~rate ~~million,~~from orour ~~3.6%~~new ofcredit ~~net~~facility ~~revenue,~~entered ~~for~~into ~~the~~in ~~same~~April 2010 ~~period in~~and ~~2009. The~~the ~~decrease~~redemption ~~was~~of ~~due~~our ~~primarily to~~senior ~~AMR’s~~subordinated ~~ability~~notes. In toconjunction ~~utilize~~with ~~fewer~~entering ~~ambulances~~into toour ~~service~~new ~~its~~credit ~~existing~~facility, ~~contracts and~~we ~~the~~reduced ~~timing~~our oftotal ~~replacing~~outstanding ~~fully~~debt ~~depreciated~~by ~~assets~~$25.0 million.

~~EmCare~~Income tax expense. Income tax expense increased by $3.2 million for the three months ended March 31, 2011 compared to the same period in 2010. Our effective tax rate was 38.6% for the three months ended March 31, 2011 and 2010.

Net revenue. Net revenue for the three months ended September 30, 2010 was $385.0 million, an increase of $58.7 million, or 18.0%, from $326.3 million for the three months ended September 30, 2009. The increase was due primarily to an increase in patient encounters from net new hospital contracts and net revenue increases in existing contracts. Following June 30, 2009, we added 39 net new contracts which accounted for a net revenue increase of $51.4 million for the three months ended September 30, 2010. Of the 39 net new contracts added since June 30, 2009, 28 were added in 2009 resulting in an incremental increase in 2010 net revenue of $43.1 million. EmCare has added 54 new contracts and terminated 43 contracts to date in 2010, resulting in an increase in net revenue of $8.3 million for the three months ended September 30, 2010. Net revenue under our “same store” contracts (contracts in existence for the entirety of both periods) increased $4.0 million, or 1.4%, for the three months ended September 30, 2010. The change is due to a 2.3% increase in revenue per weighted patient encounter, offset partially by a decrease in same store weighted patient encounters of 0.9% from the prior period.

Compensation and benefits. Compensation and benefits costs for the three months ended September 30, 2010 were $301.8 million, or 78.4% of net revenue, compared to $255.7 million, or 78.4% of net revenue, for the same period in 2009. Provider compensation and benefits costs increased $44.1 million from net new contract additions. Same store provider compensation and benefits costs were $2.5 million below the prior period due primarily to a 0.9% decrease in same store weighted patient encounters. Non-provider compensation and total benefits costs increased by $4.7 million due primarily to our recent acquisitions and $0.5 million due to increased medical claim charges associated with our self-insured health plans.

Operating expenses. Operating expenses for the three months ended September 30, 2010 were $11.3 million, or 2.9% of net revenue, compared to $9.8 million, or 3.0% of net revenue, for the same period in 2009. Operating expenses increased $1.5 million due primarily to higher collection agency and billing fees incurred in connection with our net new contracts added since June 30, 2009 and the expansion of our anesthesiology and radiology businesses.

Insurance expense. Professional liability insurance expense for the three months ended September 30, 2010 was $16.4 million, or 4.3% of net revenue, compared to $14.4 million, or 4.4% of net revenue, for the three months ended September 30, 2009. We recorded an increase in prior year insurance provisions of $3.2 million for the three months ended September 30, 2010 and $1.3 million for the same period in 2009.

Selling, general and administrative. Selling, general and administrative expense for the three months ended September 30, 2010 was $7.3 million, or 1.9% of net revenue, compared to $6.5 million, or 2.0% of net revenue, for the three months ended September 30, 2009.

Depreciation and amortization. Depreciation and amortization expense for the three months ended September 30, 2010 was $5.2 million, or 1.4% of net revenue, compared to $3.5 million, or 1.1% of net revenue, for the three months ended September 30, 2009. The $1.7 million increase was due primarily to additional amortization expense associated with contract intangible assets recorded on acquisitions completed subsequent to June 30, 2009.

Nine months ended September 30, 2010 compared to the nine months ended September 30, 2009

Consolidated

Our results for the nine months ended September 30, 2010 reflect an increase in net revenue of $210.0 million and an increase in net income of $9.8 million compared to the nine months ended September 30, 2009. The increase in net income is attributable primarily to growth in income from operations and a decrease in interest expense, partially offset by the loss on early debt extinguishment. Basic and diluted earnings per share were $2.09 and $2.06, respectively, for the nine months ended September 30, 2010. Basic and diluted earnings per share were $1.93 and $1.89, respectively, for the same period in 2009. The basic and diluted earnings per share for the nine months ended September 30, 2010 include the impact from the loss on early debt extinguishment and a reserve recorded in connection with a tentative legal settlement relating to certain AMR affiliates in New York. These items were recorded in the second quarter of 2010 and account for basic and diluted earnings per share of $0.31 and $0.30, respectively, for the nine months ended September 30, 2010.

Net revenue. For the nine months ended September 30, 2010, net revenue was $2,125.3 million compared to $1,915.4 million for the nine months ended September 30, 2009, representing an increase of 11.0%. The increase is attributable primarily to

Table of Contents

increases in revenues on existing contracts and increased volume from net new contracts and acquisitions.

Adjusted EBITDA. Adjusted EBITDA was $232.9 million, or 11.0% of net revenue, for the nine months ended September 30, 2010 compared to $210.8 million, or 11.0% of net revenue for the nine months ended September 30, 2009.

Interest expense. Interest expense for the nine months ended September 30, 2010 was $18.2 million compared to $30.7 million for the nine months ended September 30, 2009. The decrease was due to entering into our new credit facility in April 2010 and the redemption of our senior subordinated notes which resulted in a decrease to our effective interest rate compared to our previous debt structure.

Income tax expense. Income tax expense increased $4.2 million for the nine months ended September 30, 2010, compared to the same period in 2009. Our effective tax rate for the nine months ended September 30, 2010 was 38.5% compared with 39.4% for the same period in 2009.

AMR

Net revenue. Net revenue for the ~~nine~~three months ended ~~September~~ March 3031, ~~2010~~2011 was $~~1,033~~364.32 million, an increase of $2227.62 million, or 2 8.21%, from $~~1,010~~337.70 million for the same period in ~~2009~~2010. The increase in net revenue was due primarily to an increase ~~in net revenue per weighted transport~~ of 34.27%, or $3215.28 million, ~~partially~~ ~~offset~~in byweighted atransport ~~decrease~~volume and an increase in net revenue per weighted transport of 03.94%, or $911.64 million~~, in weighted transport volume~~. The increase in net revenue per weighted transport of 3.24% was due to a 1.8% increase in ~~rates~~net revenue per transport resulting from a higher mix of emergency versus non-emergency transports and rate increases in several markets, with the remaining increase coming from growth in our managed transportation business ~~combined~~. ~~with~~AMR’s ~~other~~managed ~~non-transport~~transportation ~~related~~business represented 6.0% of AMR’s net revenue ~~increases~~for the quarter ended March 31, 2011 compared to 4.5% for the quarter ended March 31, 2010. Weighted transports ~~decreased~~increased 2033,700 from the same ~~period~~quarter last year. ~~This~~The change was due to aan ~~decrease~~increase in weighted transport volume in existing markets of 1.3.0%, or 2821,~~400~~100 weighted transports, ~~due~~ toan ~~the~~increase ~~exit~~ of ~~certain~~9,700 ~~contracts~~weighted intransports ~~existing~~from ~~markets~~acquisitions, and aan ~~decrease~~increase of 13 4,~~500~~200 weighted transports from ~~the~~our ~~exit~~entry ofinto ~~certain~~new markets, which ~~decreases~~ increases were partially offset by ana ~~increase~~decrease of 211,~~200~~300 weighted transports from ~~our entry~~the ~~into~~exit ~~new~~of certain markets.

Compensation and benefits. Compensation and benefit costs for the ~~nine~~three months ended ~~September~~March 3031, ~~2010~~2011 were $~~641~~222.10 million, or 6261.0% of net revenue, compared to $~~628~~208.04 million, or 6261.18% of net revenue, for the same period ~~in 2009~~last year. Ambulance crew wages per ambulance unit hour increased by approximately 4 2.7%, or $163.01 million, attributable primarily to annual wage rate increases. Ambulance unit hours ~~decreased~~increased period over period by 2 3.23%, or $73.8 million, due primarily to ~~the reduction in volume in existing markets and increased efficiency in~~ our ~~ambulance~~entry ~~unit~~into ~~hour~~new ~~deployment~~markets. ~~During~~Non-crew ~~the~~compensation ~~nine~~increased ~~months~~period ~~ended~~over ~~September 30, 2010,~~period weby ~~incurred~~ $2.51 million indue ~~increased~~primarily ~~medical~~to ~~claim~~acquisitions ~~charges~~and ~~associated with~~increases ~~several large claims~~ in our ~~self-insured~~managed ~~health~~transportation ~~plans~~business. ~~compared~~Total tobenefits ~~the~~related ~~same period~~costs inincreased ~~2009~~$4. We6 ~~have~~million ~~historically~~due ~~not seen~~primarily ~~the~~to ~~number~~increases ~~and~~in ~~types~~payroll oftaxes ~~large~~and ~~claims~~higher wecosts ~~incurred~~for inour ~~the~~health ~~third~~insurance ~~quarter of 2010~~plans.

Operating expenses. Operating expenses for the ~~nine~~three months ended ~~September~~ March 3031, ~~2010~~2011 were $~~233~~84.83 million, or 2223.61% of net revenue, compared to $~~222~~75.36 million, or 22.04% of net revenue, for the ~~nine~~three months ended ~~September~~ March 3031, ~~2009~~2010. The change is due primarily to increased ~~fuel~~ costs ~~of $3.8 million, increased costs~~ associated with ~~growth in~~ our managed transportation business of $46.52 million, and aan ~~$3.1~~increase ~~million reserve recorded~~ in ~~connection~~fuel ~~with~~costs aof ~~previously~~$1.7 ~~disclosed tentative legal settlement relating to certain AMR affiliates in New York~~million.

Insurance expense. Insurance expense for the ~~nine~~three months ended ~~September~~ March 3031, ~~2010~~2011 was $3311.39 million, or 3.23% of net revenue, compared to $3511.42 million, or 3.53% of net revenue, for the same period in ~~2009~~2010. We recorded aan ~~reduction~~increase of prior year insurance provisions of $20.98 million during the ~~nine~~three months ended ~~September~~March 3031, ~~2010~~2011 ~~and~~compared to a decrease of $0.29 million during the ~~same period~~three inmonths ~~2009~~ended March 31, 2010.

Selling, general and administrative. Selling, general and administrative expense for the ~~nine~~three months ended ~~September~~March 3031, ~~2010~~2011 was $3010.46 million, or 2.9% of net revenue, compared to $289.37 million, or 2.89% of net revenue, for the ~~nine~~three months ended ~~September~~March 3031, ~~2009~~2010.

Depreciation and amortization. Depreciation and amortization expense for the ~~nine~~ three months ended ~~September~~March 3031, ~~2010~~2011 was $3311.6 million, or 3.32% of net revenue, compared to $3711.12 million, or 3.73% of net revenue, for the same period in ~~2009. The decrease was due to a $2.6 million reduction~~ in ~~depreciation~~ ~~expense related primarily to AMR’s ability to utilize fewer ambulances to service its existing contracts and the timing of replacing fully depreciated assets~~2010. ~~Amortization expense also decreased by $0.9 million as certain contract-related intangible assets were fully amortized.~~

EmCare

Net revenue. Net revenue for the ~~nine~~three months ended ~~September~~ March 3031, ~~2010~~2011 was $~~1,092~~396.06 million, an increase of $~~187~~54.32 million, or 20 15.78%, from $~~904~~342.74 million for the ~~nine~~three months ended ~~September~~March 3031, ~~2009~~2010. The increase was due primarily to an increase in patient encounters from net new hospital contracts and net revenue increases in existing contracts. Following December 31, 2009, we added 44 net new contracts which accounted for a net revenue increase of $43.3 million for the three months ended March 31, 2011. Of the 44 net new contracts added since December 31, 2009, 40 were added in 2010 resulting in an incremental increase in 2011 net revenue of $43.1 million. EmCare has added 25 new contracts and terminated 21 contracts to date in 2011, resulting in an increase in net revenue of $0.2 million for the three months ended March 31, 2011. Net revenue under our “same store” contracts (contracts in existence for the entirety of both periods) increased $15.5 million, or 5.5%, for the three months ended March 31, 2011. The change was due primarily to a 7.1% increase in same store weighted patient encounters, partially offset by a 1.6% decrease in revenue per weighted patient encounter. The increase in same store net revenue was due primarily to additional volume, partially offset by a lower average charge per patient, related to a stronger flu season in the first quarter of 2011 compared to the same period in 2010.

27Compensation and benefits. Compensation and benefits costs for the three months ended March 31, 2011 were $315.0 million, or 79.4% of net revenue, compared to $272.0 million, or 79.4% of net revenue, for the same period in 2010. Provider

Table of Contents

~~patient~~compensation ~~encounters~~costs ~~from~~increased ~~net new hospital contracts and net revenue increases in existing contracts. Following December 31, 2008, we added 64 net new contracts which accounted for a net revenue increase of~~ $~~137~~32.13 million ~~for~~from ~~the nine months ended September 30, 2010. Of the 64~~ net new ~~contracts~~contract ~~added since December 31, 2008, 53 were added in 2009 resulting in an incremental increase in 2010 net revenue of $117~~additions.8 ~~million. EmCare~~Same has added 54 new contracts and terminated 43 contracts to date in 2010, resulting in an increase in net revenue of $19.3 million for the nine months ended September 30, 2010. Net revenue under our “same store” ~~contracts~~provider ~~(contracts~~compensation incosts ~~existence~~were ~~for the entirety of both periods) increased~~ $377.90 million, orhigher ~~5.3%,~~than ~~for~~ the ~~nine~~prior ~~months~~period ~~ended September 30, 2010. The change is~~ due primarily to a 47.01% increase in ~~revenue per weighted patient encounter and an increase in~~ same store weighted patient encounters, ~~of 1.3%~~partially ~~over~~offset ~~the~~by ~~prior~~a ~~period~~3. ~~The~~5% ~~number~~decrease ~~of current~~in ~~period~~provider ~~same~~compensation ~~store~~per weighted patient ~~encounters increased 1~~encounter.3% Non-provider ~~compared to~~compensation ~~the~~and ~~prior~~total ~~period~~benefits ~~notwithstanding~~costs increased ~~volume~~by ~~during~~$3.7 ~~2009~~million ~~from~~due ~~the~~primarily ~~H1N1 virus~~to ~~and~~our ~~from~~recent aacquisitions ~~milder~~and ~~flu~~organic ~~season in 2010~~growth.

~~Compensation and~~Operating ~~benefits~~expenses. ~~Compensation~~Operating ~~and~~expenses ~~benefits costs~~ for the ~~nine~~three months ended ~~September~~March 3031, ~~2010~~2011 were $~~858~~12.97 million, or 783.72% of net revenue, compared to $~~704~~10.89 million, or 773.92% of net revenue, for the same period in ~~2009.~~ ~~Provider compensation and benefits costs increased $113~~2010.0 million from net new contract additions. Same store provider compensation and benefits costs were $25.9 million over the prior period due to a 4.1% increase in provider compensation per weighted patient encounter and a 1.3% increase in same store weighted patient encounters. ~~Non-provider compensation~~Operating ~~and~~expenses ~~total benefits costs~~ increased by $161.08 million due primarily to our recent acquisitions and ~~$0.5~~organic ~~million due to increased medical claim charges associated with our self-insured health plans~~growth.

~~Operating expenses~~Insurance expense. ~~Operating~~Professional ~~expenses~~liability insurance expense for the ~~nine~~three months ended ~~September~~ March 3031, ~~2010~~2011 ~~were~~was $3414.37 million, or 3.17% of net revenue, compared to $3010.19 million, or 3.32% of net revenue, for the ~~same~~three ~~period~~months inended ~~2009.~~March ~~Operating~~31, ~~expenses increased $4~~2010.2 We ~~million~~recorded ~~due~~an ~~primarily~~increase toof ~~higher~~prior ~~collection agency~~year ~~and~~insurance ~~billing~~provisions ~~fees~~of ~~incurred~~$1.7 inmillion ~~connection~~during ~~with~~the ~~our~~three ~~net~~months ~~new~~ended ~~contracts added since December~~March 31, ~~2008~~2011 ~~and~~compared ~~the~~to ~~expansion~~a decrease of ~~our~~$1.9 ~~anesthesiology~~million ~~and radiology~~during ~~businesses~~the three months ended March 31, 2010.

~~Insurance expense~~Selling, general and administrative. ~~Professional~~Selling, ~~liability~~general ~~insurance~~and administrative expense for the ~~nine~~three months ended ~~September~~March 3031, ~~2010~~2011 was $407.52 million, or 31.78% of net revenue, compared to $407.31 million, or 42.51% of net revenue, for the ~~nine~~three months ~~ended~~ ~~September 30, 2009. We recorded an increase of prior year insurance provisions of $3.2 million during the nine months~~ ended ~~September~~March 3031, 2010 ~~and $4~~.~~5 million during the same period in 2009.~~

~~Selling, general~~Depreciation and ~~administrative~~amortization. ~~Selling,~~Depreciation ~~general~~ and ~~administrative~~ amortization expense for the ~~nine~~three months ended ~~September~~March 3031, ~~2010~~2011 was $226.50 million, or 2.1.5% of net revenue, compared to $184.9 million, or 2.1.4% of net revenue, for the ~~nine~~three months ended ~~September~~March 3031, ~~2009~~2010. The $31.6 1 million increase ~~was~~is due primarily to ~~growth~~additional inamortization ~~the~~expense ~~number~~associated ofwith ~~net~~contract ~~new~~intangible ~~contracts~~ assets recorded on acquisitions completed since December 31, ~~2008~~2009.

Depreciation and amortization. Depreciation and amortization expense for the nine months ended September 30, 2010 was $14.8 million, or 1.4% of net revenue, compared to $11.5 million, or 1.3% of net revenue, for the nine months ended September 30, 2009. The $3.3 million increase was due primarily to additional amortization expense associated with contract intangible assets recorded on acquisitions completed subsequent to December 31, 2008.

Critical Accounting Policies

For a discussion of accounting policies that we consider critical to our business operations and the understanding of our results of operations that affect the more significant judgments and estimates used in the preparation of our unaudited condensed consolidated financial statements, please refer to Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies” contained in our annual report on Form 10-K for the year ended ~~December 31, 2009 and incorporated by reference herein. As of September 30, 2010, there were no significant changes in our critical accounting policies or estimation procedures.~~

December 31, 2010 and incorporated by reference herein. As of March 31, 2011, there were no significant changes in our critical accounting policies or estimation procedures.

Liquidity and Capital Resources

Our primary source of liquidity is cash flows provided by our operating activities. We can also use our revolving senior secured credit facility, described below, to supplement cash flows provided by our operating activities if we decide to do so for strategic or operating reasons. Our liquidity needs are primarily to service long-term debt and to fund working capital requirements, capital expenditures related to the acquisition of vehicles and medical equipment, technology-related assets and insurance-related deposits.

OnWe ~~April 8~~believe our cash and cash equivalents, ~~2010~~cash provided by our operating activities, ~~we completed~~and ~~the~~amounts ~~financing~~available ofunder ~~new~~our senior secured credit ~~facilities,~~facility ~~which~~will ~~is further~~meet ~~described~~the inliquidity ~~note~~requirements 5 of ~~the~~our ~~notes~~business ~~accompanying~~through at least the ~~unaudited consolidated~~next ~~financial~~12 ~~statements~~months. ~~In conjunction~~ ~~with~~We ~~completing~~have ~~this~~available ~~financing~~to us, weupon ~~repaid~~compliance with customary conditions, $150 million under the ~~balance~~revolving credit facility, less any letters of credit outstanding on. As ~~the~~of ~~previous~~March 31, ~~senior~~2011, ~~secured~~outstanding ~~term~~letters ~~loan~~of ~~and~~credit ~~redeemed~~which impacted our ~~10%~~available ~~senior subordinated~~credit ~~notes~~under the revolving credit facility totaled $47. ~~These~~3 ~~transactions reduce~~million. As of March 31, 2011, EMCA Insurance Company, Ltd., our ~~effective~~captive ~~interest~~insurance ~~rate~~company, ~~compared~~also tohad ~~the~~letters ~~rate~~of ~~under~~credit ~~our~~outstanding ~~previous~~which ~~debt structure~~totaled $27.4 million.

Table of Contents

We believe our cash and cash equivalents, cash provided by our operating activities, and amounts available under our senior secured credit facility will meet the liquidity requirements of our business through at least the next 12 months. We have available to us, upon compliance with customary conditions, $150.0 million under the revolving credit facility, less outstanding letters of credit of $47.3 million at September 30, 2010.

Cash Flow

The table below summarizes cash flow information derived from our statements of cash flows for the periods indicated, amounts in thousands.

	Nine months ended September 30, 2010			Nine months ended September 30, 2009
	Quarter ended March 31,
	2011			2010
Net cash provided by (used in):
Operating activities	$	~~139~~71,~~365~~999		$	~~209~~44,~~801~~585
Investing activities	(8035,~~785~~136		)	(317,~~674~~118		)
Financing activities	~~(45~~10,~~752~~548		)	610,~~805~~700

Operating activities. Net cash provided by operating activities was $~~139~~72.40 million for the ~~nine~~three months ended ~~September~~March 3031, ~~2010~~2011 compared to $~~209~~44.86 million for the same period ~~last~~in ~~year~~2010. ~~Cash~~The ~~paid~~change ~~for~~in ~~income taxes increased $45.7 million due to utilization of our net~~ operating ~~loss carryforwards in 2009. Trade and other accounts receivable decreased~~ cash flows ~~from~~was ~~operations~~affected ~~$30.4 million during the nine months ended September 30, 2010~~ primarily ~~due~~by toan ~~revenue~~increase ~~growth~~in ~~and increased~~net ~~days~~income ~~sales~~combined ~~outstanding,~~with orchanges ~~DSO,~~ in ~~our~~operating ~~AMR~~assets ~~segment due to temporary Medicare~~ and ~~Medicaid~~liabilities ~~delays~~ and the ~~timing~~cash offlow ~~receipts~~benefit ~~for~~related ~~our~~to ~~expanded managed transportation business, which represented 3 days of AMR’s DSO as of September 30, 2010.~~tax

We regularly analyze DSO which is calculated by taking our net revenue for the quarter divided by the number of days in the quarter. The result is divided into net accounts receivable at the end of the period. DSO provides us with a gauge to measure receivables, revenue and collection activities. The reductions since June 30, 2009 shown below are due to additional collections on accounts receivable as a result of continued billing and collection process enhancements at both AMR and EmCare. The following table outlines our DSO by segment and in total excluding the impact of acquisitions completed within the specific quarter:24

	Q3 2010	Q2 2010	Q1 2010	Q4 2009	Q3 2009	Q2 2009
AMR	70	68	66	68	70	73
EmCare	54	55	56	60	58	61
EMSC	61	62	61	64	64	67

Investing activities. Net cash used in investing activities was $80.8 million for the nine months ended September 30, 2010 compared to $31.7 million for the same period in 2009. The increase in cash used in investing activities relates to $51.2 million used in the acquisition of businesses during 2010. Additionally, cash used for insurance collateral requirements increased by $13.5 million during the nine months ended September 30, 2010 compared to the same period in 2009. These changes in cash used in investing activities were offset by an increase in cash provided by other investing activities of $11.8 million during the nine months ended September 30, 2010 compared to the same period in 2009 due primarily to the return of performance bond collateral.

Financing activities. For the nine months ended September 30, 2010, net cash used in financing activities was $45.8 million compared to $6.8 million in net cash provided by financing activities for the nine months ended September 30, 2009. During the nine months ended September 30, 2010 we incurred $12.0 million in debt issuance costs related to our new credit facility and used $25.0 million to reduce our total outstanding debt. We also incurred $14.5 million in cash payments related to the redemption of our senior subordinated notes during the nine months ended September 30, 2010. This is offset by the cash flow benefit related to tax deductions for stock-based compensation during the nine months ended September 30, 2010. At September 30, there were no amounts outstanding under our revolving credit facility.

Table of Contents

deductions from stock-based compensation, which has been reported as an increase in financing cash flows. Accounts payable and accrued liabilities increased cash flows from operations $29.1 million during the three months ended March 31, 2011 compared to $6.0 million during the three months ended March 31, 2010. The change is due primarily to the timing of income tax related payments, and lower incentive compensation payments during the three months ended March 31, 2011 compared to the same period in 2010. Accounts receivable increased $10.8 million and days sales outstanding, or DSO, decreased 1 day during the three months ended March 31, 2011.

We regularly analyze DSO which is calculated by dividing our net revenue for the quarter by the number of days in the quarter. The result is divided into net accounts receivable at the end of the period. DSO provides us with a gauge to measure receivables, revenue and collection activities. The reductions since December 31, 2009 shown below are due to additional collections on accounts receivable as a result of continued billing and collection enhancements at both AMR and EmCare. The following table outlines our DSO by segment and in total excluding the impact of acquisitions completed within the specific quarter:

	Q1 2011	Q4 2010	Q3 2010	Q2 2010	Q1 2010	Q4 2009
AMR	66	69	70	68	66	68
EmCare	54	54	54	55	56	60
EMSC	60	61	61	62	61	64

Investing activities. Net cash used in investing activities was $35.1 million for the three months ended March 31, 2011 compared to $7.1 million for the same period in 2010. The change relates primarily to increases in acquisition activity. Acquisitions of businesses totaled $32.7 million during the three months ended March 31, 2011 compared to $3.3 million during the same period in 2010.

Financing activities. Net cash provided by financing activities was $10.5 million for the three months ended March 31, 2011 compared to $10.7 million for the same period in 2010. At March 31, 2011, there were no amounts outstanding under our revolving credit facility.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our primary exposure to market risk consists of changes in interest rates on certain of our borrowings and changes in fuel prices. While we have from time to time entered into transactions to mitigate our exposure to both changes in interest rates and fuel prices, we do not use these instruments for speculative or trading purposes.

We manage our exposure to changes in ~~market interest rates and~~ fuel prices and, as appropriate, use highly effective derivative instruments to manage well-defined risk exposures. As of ~~September~~March 3031, ~~2010~~2011, we were party to a series of fuel hedge transactions with a major financial institution under one master agreement. Each of the transactions effectively fixes the cost of diesel fuel at prices ranging from $3.0007 to $3.29 per gallon. We purchase the diesel fuel at the market rate and periodically settle with our counterparty for the difference between the national average price for the period published by the Department of Energy and the agreed upon fixed price. The transactions fix the price for a total of 53.9 million gallons, ~~which represent approximately 32% of our total estimated usage over the hedge period,~~ and are spread over periods from ~~October~~April ~~2010~~2011 through June 2012. As of December 31, 2009, we were party to a series of transactions under the same master agreement with fuel prices ranging from $2.91 to $3.15 per gallon for 2.7 million gallons of fuel, or 26% of our total estimated usage at that time.

As of ~~September~~March 3031, ~~2010~~ 2011, we had $~~423~~418.56 million of debt, excluding capital leases, of which $~~422~~417.3 0 million was variable rate debt under our senior secured credit facility and the balance was fixed rate debt. An increase or decrease in interest rates of 0.2% will impact our interest costs by $0.8 million annually.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)) that are designed to ensure that information required to be disclosed in the reports that we file under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or furnishes under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Table of Contents

Based on their evaluation of our disclosure controls and procedures conducted within 90 days of the date of filing this Report on Form 10-Q, our principal executive officer and our principal financial officer have concluded that, as of the date of their evaluation, our disclosure controls and procedures (as defined in Rules 13a -15(e) and 15d -15(e) promulgated under the Exchange Act) are effective.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during our fiscal quarter ended ~~September~~March 3031, ~~2010~~2011 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

3026

Table of Contents

EMERGENCY MEDICAL SERVICES CORPORATION

PART II. OTHER INFORMATION

FOR THE THREE ~~AND NINE~~ MONTHS ENDED

~~SEPTEMBER 30~~MARCH 31, ~~2010~~2011

ITEM 1. LEGAL PROCEEDINGS

AsFor ~~referenced~~additional ininformation ~~our~~regarding ~~Annual Report~~legal ~~on Form 10-K for the year ended December 31~~proceedings, ~~2009,~~please arefer ~~lawsuit purporting~~ to benote ~~a class action was commenced against AMR in Spokane~~7, ~~Washington~~under ~~in Washington~~the ~~State~~caption ~~Court,~~“Commitments ~~Spokane~~and ~~County.~~Contingencies” Inof ~~September~~the ~~2010,~~notes weaccompanying ~~reached an agreement with class representatives to resolve~~ the ~~claims~~consolidated ~~for~~financial ~~approximately $1.1~~statements ~~million~~included herein, ~~which amount includes all remaining refunds due to class members~~ and ~~attorney’s fees for the plaintiffs’ counsel. The settlement is expected~~ to beour ~~approved~~Annual ~~and finalized~~Report byon ~~the~~Form 10-K ~~court~~filed bywith the ~~end~~SEC ofon ~~January~~February 18, 2011.

~~For~~Eleven ~~additional~~purported ~~information regarding~~shareholder ~~legal~~class ~~proceedings~~actions relating to the transactions contemplated by the Agreement and Plan of Merger, ~~please~~dated ~~refer~~as toof ~~note~~February 713, ~~under~~2011, ~~the~~among ~~caption~~EMSC, ~~“Commitments~~ CDRT Acquisition Corporation and ~~Contingencies~~CDRT Merger Sub, Inc. (the “Merger Agreement”), have been filed in state court in Delaware and federal and state courts in Colorado against various combinations of EMSC, the ~~notes~~members ~~accompanying~~of our board of directors, and other parties. Seven actions were filed in the ~~consolidated~~Delaware ~~financial statements~~Court ~~included~~of ~~herein~~Chancery beginning on February 22, to2011, ~~our~~which ~~Annual~~have ~~Report~~since onbeen ~~Form~~consolidated into one action entitled In re Emergency Medical Services Corporation Shareholder Litigation, Consolidated C.A. No. 106248-KVCS. ~~filed~~On ~~with~~ April 4, 2011, the ~~SEC~~Delaware plaintiffs filed their consolidated class action complaint. Two actions, entitled Scott A. Halliday v. Emergency Medical Services Corporation, et al., Case No. 2011CV316 (filed on February 1915, ~~2010~~2011), and toAlma ~~our~~C. ~~Quarterly~~Howell ~~Reports~~v. William Sanger, et. al., Case No. 2011CV488 (filed on ~~Form~~March 101, 2011), were filed in the District Court, Arapahoe County, Colorado. Two other actions, entitled Michael Wooten v. Emergency Medical Services Corporation, et al., Case No. 11-Q CV-00412 (filed ~~with~~on February 17, 2011) (the ~~SEC~~“Wooten action”), and Neal Greenberg v. Emergency Medical Services Corporation, et. al., Case No. 11-CV-00496 (filed on ~~May~~February 428, ~~2010~~2011), were filed in the U.S. District Court for the District of Colorado. These actions generally allege that the directors of EMSC, Onex Corporation and/or ~~August~~Onex 5Corporation’s subsidiaries breached their fiduciary duties by, ~~2010~~among other things: approving the transactions contemplated by the Merger Agreement, which allegedly were financially unfair to EMSC and its public stockholders; agreeing to provisions in the Merger Agreement that will allegedly prevent the board from considering other offers; permitting the unitholders agreement (which secures the majority votes in favor of the merger contemplated by the Merger Agreement (the “Merger”)) and failing to require a provision in the Merger Agreement requiring that a majority of the public stockholders approve the transactions contemplated by the Merger Agreement; and/or making allegedly materially inadequate disclosures. These actions further allege that certain defendants aided and abetted these breaches. In addition, the two actions filed in the U.S. District Court for the District of Colorado contain individual claims brought under Section 14(a) and Section 20(a) of the Securities Exchange Act of 1934, as amended, pertaining to the purported dissemination of allegedly misleading proxy materials. These actions seek unspecified damages and equitable relief, including an injunction halting the Merger or rescission of the Merger, as applicable. The plaintiffs in the consolidated Delaware action have filed a motion for a preliminary injunction. We believe that all of the allegations in these actions are without merit and intend to vigorously defend these matters. If any one of the plaintiffs is successful in obtaining an injunction prohibiting the completion of the Merger on the agreed-upon terms, then such injunction may prevent the Merger from becoming effective, or from becoming effective within the expected timeframe.

ITEM 1A. RISK FACTORS

There have been no material changes from the risk factors disclosed in the “Risk Factors” ~~sections~~section of EMSC’s Annual Report on Form 10-K for the year ended December 31, ~~2009~~2010.

Table of Contents

ITEM 2. ISSUER PURCHASES OF EQUITY SECURITIES

Period	Total Number of Shares Purchased		Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number (or Approximate Dollar Value) of Shares that may yet be Purchased under the Plans or Programs
July 1, 2010 through July 31, 2010	—		—		—	N/A
January 1, 2011 through January 31, 2011	—		—		—	N/A
August 1, 2010 through August 31, 2010	—		—		—	N/A
February 1, 2011 through February 28, 2011	—		—		—	N/A
September 1, 2010 through September 30, 2010	23,437	(1)	$	54.99	—	N/A
March 1, 2011 through March 31, 2011	20,469	(1)	$	63.66	—	N/A

(1) Represents ~~shares~~ ~~delivered to the Company from~~ shares of restricted stock held by employees under the Company’s Amended and Restated Long-Term Incentive Plan ~~held~~and ~~by certain~~delivered ~~employees~~to the Company upon vesting ~~for~~to ~~the~~satisfy ~~purpose of covering~~ the recipients’ tax withholding obligation to the Company.

3128

Table of Contents

ITEM 6. EXHIBITS

10.14.4		Form of 2007 LTIP Revised Named Executive Officer Restricted Stock Agreement.*
	2.1		Agreement and Plan of Merger, among CDRT Acquisition Corporation, CDRT Merger Sub, Inc. and Emergency Medical Services Corporation, dated as of February 13, 2011 (incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on February 17, 2011).
10.14.5		Form of 2007 LTIP Revised Restricted Stock Agreement.*
	2.2		Unitholders Agreement, among Emergency Medical Services Corporation, Emergency Medical Services L.P., CDRT Acquisition Corporation, CDRT Merger Sub, Inc. and Onex Corporation, solely in its capacity as Trustee under the Voting and Exchange Trust Agreement, dated December 2005 among Emergency Medical Services Corporation, Emergency Medical Services L.P. and Onex Corporation, and the Limited Partners listed on the signature pages thereto, dated as of February 13, 2011 (incorporated by reference to Exhibit 2.2 of the Current Report on Form 8-K filed on February 17, 2011).
~~31.1~~	31.1	Certification of the Chief Executive Officer of Emergency Medical Services Corporation pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*	Certification of the Chief Executive Officer of Emergency Medical Services Corporation pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
~~31.2~~	31.2	Certification of the Chief Executive Officer of Emergency Medical Services Corporation, as general partner of Emergency Medical Services L.P., pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*	Certification of the Chief Executive Officer of Emergency Medical Services Corporation, as general partner of Emergency Medical Services L.P., pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
~~31.3~~	31.3	Certification of the Chief Financial Officer of Emergency Medical Services Corporation pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*	Certification of the Chief Financial Officer of Emergency Medical Services Corporation pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
~~31.4~~	31.4	Certification of the Chief Financial Officer of Emergency Medical Services Corporation, as general partner of Emergency Medical Services L.P., pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*	Certification of the Chief Financial Officer of Emergency Medical Services Corporation, as general partner of Emergency Medical Services L.P., pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
~~32.1~~	32.1	Certification of the Chief Executive Officer and the Chief Financial Officer of Emergency Medical Services Corporation pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**	Certification of the Chief Executive Officer and the Chief Financial Officer of Emergency Medical Services Corporation pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
~~32.2~~	32.2	Certification of the Chief Executive Officer and the Chief Financial Officer of Emergency Medical Services Corporation, as general partner of Emergency Medical Services L.P. pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**	Certification of the Chief Executive Officer and the Chief Financial Officer of Emergency Medical Services Corporation, as general partner of Emergency Medical Services L.P. pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
	101		The following materials from EMSC’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011 formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Statements of Operations and Comprehensive Income, (ii) the Consolidated Balance Sheets, (iii) the Consolidated Statements of Cash Flows, (iv) Notes to the Unaudited Consolidated Financial Statements.*

* Filed with this Report

** Furnished with this Report29

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.

	EMERGENCY MEDICAL SERVICES CORPORATION
	(registrant)
November 4, 2010	By:	/s/ William A. Sanger
May 4, 2011	By:	/s/ William A. Sanger
Date		William A. Sanger
		Chairman and Chief Executive Officer
	By:	/s/ Randel G. Owen
		Randel G. Owen
		Chief Financial Officer and Executive Vice President
	EMERGENCY MEDICAL SERVICES L.P.
	(registrant)
	By:	Emergency Medical Services Corporation, its General Partner
November 4, 2010	By:	/s/ William A. Sanger
May 4, 2011	By:	/s/ William A. Sanger
Date		William A. Sanger
		Chairman and Chief Executive Officer
	By:	/s/ Randel G. Owen
		Randel G. Owen
		Chief Financial Officer and Executive Vice President

3330

Table of Contents

EXHIBIT INDEX

10.14.4		Form of 2007 LTIP Revised Named Executive Officer Restricted Stock Agreement.*
2.1		Agreement and Plan of Merger, among CDRT Acquisition Corporation, CDRT Merger Sub, Inc. and Emergency Medical Services Corporation, dated as of February 13, 2011 (incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on February 17, 2011).
10.14.5		Form of 2007 LTIP Revised Restricted Stock Agreement.*
2.2		Unitholders Agreement, among Emergency Medical Services Corporation, Emergency Medical Services L.P., CDRT Acquisition Corporation, CDRT Merger Sub, Inc. and Onex Corporation, solely in its capacity as Trustee under the Voting and Exchange Trust Agreement, dated December 2005 among Emergency Medical Services Corporation, Emergency Medical Services L.P. and Onex Corporation, and the Limited Partners listed on the signature pages thereto, dated as of February 13, 2011 (incorporated by reference to Exhibit 2.2 of the Current Report on Form 8-K filed on February 17, 2011).
31.1		Certification of the Chief Executive Officer of Emergency Medical Services Corporation pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2		Certification of the Chief Executive Officer of Emergency Medical Services Corporation, as general partner of Emergency Medical Services L.P., pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.3		Certification of the Chief Financial Officer of Emergency Medical Services Corporation pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.4		Certification of the Chief Financial Officer of Emergency Medical Services Corporation, as general partner of Emergency Medical Services L.P., pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1		Certification of the Chief Executive Officer and the Chief Financial Officer of Emergency Medical Services Corporation pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
32.2		Certification of the Chief Executive Officer and the Chief Financial Officer of Emergency Medical Services Corporation, as general partner of Emergency Medical Services L.P. pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
101		The following materials from EMSC’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011 formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Statements of Operations and Comprehensive Income, (ii) the Consolidated Balance Sheets, (iii) the Consolidated Statements of Cash Flows, (iv) Notes to the Unaudited Consolidated Financial Statements.*

* Filed with this Report

** Furnished with this Report31

Filing Compare · Emergency Medical Services L.P.